BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alix-Panabières C, Pantel K. Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy. Cancer Discov. 2016;6:479-491. [PMID: 26969689 DOI: 10.1158/2159-8290.cd-15-1483] [Cited by in Crossref: 696] [Cited by in F6Publishing: 383] [Article Influence: 116.0] [Reference Citation Analysis]
Number Citing Articles
1 Jia W, Gao Q, Han A, Zhu H, Yu J. The potential mechanism, recognition and clinical significance of tumor pseudoprogression after immunotherapy. Cancer Biol Med. 2019;16:655-670. [PMID: 31908886 DOI: 10.20892/j.issn.2095-3941.2019.0144] [Cited by in F6Publishing: 15] [Reference Citation Analysis]
2 Pauli C, Moch H, Rubin MA. [Establishment of a living biobank : Improved guidance of precision cancer care with in vitro and in vivo cancer models]. Pathologe 2017;38:160-8. [PMID: 28956107 DOI: 10.1007/s00292-017-0346-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Yang D, Yang X, Li Y, Zhao P, Fu R, Ren T, Hu P, Wu Y, Yang H, Guo N. Clinical significance of circulating tumor cells and metabolic signatures in lung cancer after surgical removal. J Transl Med 2020;18:243. [PMID: 32552826 DOI: 10.1186/s12967-020-02401-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
4 Dama E, Melocchi V, Colangelo T, Cuttano R, Bianchi F. Deciphering the Molecular Profile of Lung Cancer: New Strategies for the Early Detection and Prognostic Stratification. J Clin Med 2019;8:E108. [PMID: 30658453 DOI: 10.3390/jcm8010108] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
5 Viëtor CL, Creemers SG, van Kemenade FJ, van Ginhoven TM, Hofland LJ, Feelders RA. How to Differentiate Benign from Malignant Adrenocortical Tumors? Cancers (Basel) 2021;13:4383. [PMID: 34503194 DOI: 10.3390/cancers13174383] [Reference Citation Analysis]
6 Krug AK, Enderle D, Karlovich C, Priewasser T, Bentink S, Spiel A, Brinkmann K, Emenegger J, Grimm DG, Castellanos-Rizaldos E, Goldman JW, Sequist LV, Soria JC, Camidge DR, Gadgeel SM, Wakelee HA, Raponi M, Noerholm M, Skog J. Improved EGFR mutation detection using combined exosomal RNA and circulating tumor DNA in NSCLC patient plasma. Ann Oncol 2018;29:700-6. [PMID: 29216356 DOI: 10.1093/annonc/mdx765] [Cited by in Crossref: 71] [Cited by in F6Publishing: 80] [Article Influence: 23.7] [Reference Citation Analysis]
7 Miller BF, Petrykowska HM, Elnitski L. Assessing ZNF154 methylation in patient plasma as a multicancer marker in liquid biopsies from colon, liver, ovarian and pancreatic cancer patients. Sci Rep 2021;11:221. [PMID: 33420235 DOI: 10.1038/s41598-020-80345-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Hernández-Barranco A, Nogués L, Peinado H. Could Extracellular Vesicles Contribute to Generation or Awakening of "Sleepy" Metastatic Niches? Front Cell Dev Biol 2021;9:625221. [PMID: 33738282 DOI: 10.3389/fcell.2021.625221] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Alama A, Coco S, Genova C, Rossi G, Fontana V, Tagliamento M, Giovanna Dal Bello M, Rosa A, Boccardo S, Rijavec E, Biello F, Longo L, Cavalieri Z, Bruzzo C, Grossi F. Prognostic Relevance of Circulating Tumor Cells and Circulating Cell-Free DNA Association in Metastatic Non-Small Cell Lung Cancer Treated with Nivolumab. J Clin Med 2019;8:E1011. [PMID: 31295929 DOI: 10.3390/jcm8071011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
10 Baumann M, Ebert N, Kurth I, Bacchus C, Overgaard J. What will radiation oncology look like in 2050? A look at a changing professional landscape in Europe and beyond. Mol Oncol 2020;14:1577-85. [PMID: 32463984 DOI: 10.1002/1878-0261.12731] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Palanca-Ballester C, Rodriguez-Casanova A, Torres S, Calabuig-Fariñas S, Exposito F, Serrano D, Redin E, Valencia K, Jantus-Lewintre E, Diaz-Lagares A, Montuenga L, Sandoval J, Calvo A. Cancer Epigenetic Biomarkers in Liquid Biopsy for High Incidence Malignancies. Cancers (Basel) 2021;13:3016. [PMID: 34208598 DOI: 10.3390/cancers13123016] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Mäurer M, Pachmann K, Wendt T, Schott D, Wittig A. Prospective Monitoring of Circulating Epithelial Tumor Cells (CETC) Reveals Changes in Gene Expression during Adjuvant Radiotherapy of Breast Cancer Patients. Curr Oncol 2021;28:3507-24. [PMID: 34590615 DOI: 10.3390/curroncol28050302] [Reference Citation Analysis]
13 Mesquita B, Rothwell DG, Burt DJ, Chemi F, Fernandez-Gutierrez F, Slane-Tan D, Antonello J, Carter M, Carter L, Parry M, Franklin L, Marais R, Blackhall F, Dive C, Brady G. Molecular analysis of single circulating tumour cells following long-term storage of clinical samples. Mol Oncol 2017;11:1687-97. [PMID: 28741788 DOI: 10.1002/1878-0261.12113] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
14 Alborelli I, Generali D, Jermann P, Cappelletti MR, Ferrero G, Scaggiante B, Bortul M, Zanconati F, Nicolet S, Haegele J, Bubendorf L, Aceto N, Scaltriti M, Mucci G, Quagliata L, Novelli G. Cell-free DNA analysis in healthy individuals by next-generation sequencing: a proof of concept and technical validation study. Cell Death Dis 2019;10:534. [PMID: 31296838 DOI: 10.1038/s41419-019-1770-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 11.3] [Reference Citation Analysis]
15 Soh J, Hamada A, Fujino T, Mitsudomi T. Perioperative Therapy for Non-Small Cell Lung Cancer with Immune Checkpoint Inhibitors. Cancers (Basel) 2021;13:4035. [PMID: 34439189 DOI: 10.3390/cancers13164035] [Reference Citation Analysis]
16 Sesé M, Somoza R, Maestu I, Ureste MM, Sanchez A, Cordoba JF, Sansano I, Venturas G, Ramón Y Cajal S, Hernández-Losa J. Validation of Cell-Free DNA Collection Tubes for Determination of EGFR Mutation Status in Liquid Biopsy from NSCLC Patients. Oncol Ther 2019;7:131-9. [PMID: 32699985 DOI: 10.1007/s40487-019-00099-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Boral D, Vishnoi M, Liu HN, Yin W, Sprouse ML, Scamardo A, Hong DS, Tan TZ, Thiery JP, Chang JC, Marchetti D. Molecular characterization of breast cancer CTCs associated with brain metastasis. Nat Commun 2017;8:196. [PMID: 28775303 DOI: 10.1038/s41467-017-00196-1] [Cited by in Crossref: 88] [Cited by in F6Publishing: 83] [Article Influence: 17.6] [Reference Citation Analysis]
18 Di Trapani M, Manaresi N, Medoro G. DEPArray™ system: An automatic image-based sorter for isolation of pure circulating tumor cells. Cytometry A 2018;93:1260-6. [PMID: 30551261 DOI: 10.1002/cyto.a.23687] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 7.7] [Reference Citation Analysis]
19 Best MG, Sol N, In 't Veld SGJG, Vancura A, Muller M, Niemeijer AN, Fejes AV, Tjon Kon Fat LA, Huis In 't Veld AE, Leurs C, Le Large TY, Meijer LL, Kooi IE, Rustenburg F, Schellen P, Verschueren H, Post E, Wedekind LE, Bracht J, Esenkbrink M, Wils L, Favaro F, Schoonhoven JD, Tannous J, Meijers-Heijboer H, Kazemier G, Giovannetti E, Reijneveld JC, Idema S, Killestein J, Heger M, de Jager SC, Urbanus RT, Hoefer IE, Pasterkamp G, Mannhalter C, Gomez-Arroyo J, Bogaard HJ, Noske DP, Vandertop WP, van den Broek D, Ylstra B, Nilsson RJA, Wesseling P, Karachaliou N, Rosell R, Lee-Lewandrowski E, Lewandrowski KB, Tannous BA, de Langen AJ, Smit EF, van den Heuvel MM, Wurdinger T. Swarm Intelligence-Enhanced Detection of Non-Small-Cell Lung Cancer Using Tumor-Educated Platelets. Cancer Cell 2017;32:238-252.e9. [PMID: 28810146 DOI: 10.1016/j.ccell.2017.07.004] [Cited by in Crossref: 99] [Cited by in F6Publishing: 101] [Article Influence: 19.8] [Reference Citation Analysis]
20 Weitzel JN, Chao EC, Nehoray B, Van Tongeren LR, LaDuca H, Blazer KR, Slavin T, Facmg DABMD, Pesaran T, Rybak C, Solomon I, Niell-Swiller M, Dolinsky JS, Castillo D, Elliott A, Gau CL, Speare V, Jasperson K. Somatic TP53 variants frequently confound germ-line testing results. Genet Med 2018;20:809-16. [PMID: 29189820 DOI: 10.1038/gim.2017.196] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 11.0] [Reference Citation Analysis]
21 Gao J, Xi L, Yu R, Xu H, Wu M, Huang H. Differential Mutation Detection Capability Through Capture-Based Targeted Sequencing in Plasma Samples in Hepatocellular Carcinoma. Front Oncol 2021;11:596789. [PMID: 33996539 DOI: 10.3389/fonc.2021.596789] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Pantel K. TP53 mutations on circulating cell-free DNA. EBioMedicine 2016;10:15-6. [PMID: 27412263 DOI: 10.1016/j.ebiom.2016.07.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
23 Rink M, Shariat SF, Soave A. Liquid biopsies in bladder cancer-did we find the Holy Grail for biomarker analyses? Transl Androl Urol 2016;5:980-3. [PMID: 28078238 DOI: 10.21037/tau.2016.09.03] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
24 Osumi H, Shinozaki E, Yamaguchi K, Zembutsu H. Clinical utility of circulating tumor DNA for colorectal cancer. Cancer Sci 2019;110:1148-55. [PMID: 30742729 DOI: 10.1111/cas.13972] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 12.0] [Reference Citation Analysis]
25 Alix-Panabières C, Pantel K. 11th International Symposium on Minimal Residual Cancer (ISMRC): 3-5 May 2018, Montpellier, France. Clin Exp Metastasis 2018;35:87-90. [PMID: 29980892 DOI: 10.1007/s10585-018-9909-7] [Reference Citation Analysis]
26 Kang Z, Stevanović S, Hinrichs CS, Cao L. Circulating Cell-free DNA for Metastatic Cervical Cancer Detection, Genotyping, and Monitoring. Clin Cancer Res 2017;23:6856-62. [PMID: 28899967 DOI: 10.1158/1078-0432.CCR-17-1553] [Cited by in Crossref: 26] [Cited by in F6Publishing: 14] [Article Influence: 5.2] [Reference Citation Analysis]
27 Crinò L, Delmonte A. Molecular targeted therapies in non-small cell lung cancer: where we are. Transl Lung Cancer Res 2019;8:S222-3. [PMID: 31857946 DOI: 10.21037/tlcr.2019.11.13] [Reference Citation Analysis]
28 Agnoletto C, Corrà F, Minotti L, Baldassari F, Crudele F, Cook WJJ, Di Leva G, d'Adamo AP, Gasparini P, Volinia S. Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset. Cancers (Basel) 2019;11:E483. [PMID: 30959764 DOI: 10.3390/cancers11040483] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 18.0] [Reference Citation Analysis]
29 Nakazawa M, Paller C, Kyprianou N. Mechanisms of Therapeutic Resistance in Prostate Cancer. Curr Oncol Rep 2017;19:13. [PMID: 28229393 DOI: 10.1007/s11912-017-0568-7] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 9.8] [Reference Citation Analysis]
30 Heitzer E, Perakis S, Geigl JB, Speicher MR. The potential of liquid biopsies for the early detection of cancer. NPJ Precis Oncol 2017;1:36. [PMID: 29872715 DOI: 10.1038/s41698-017-0039-5] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 13.4] [Reference Citation Analysis]
31 Sho S, Court CM, Winograd P, Lee S, Hou S, Graeber TG, Tseng HR, Tomlinson JS. Precision oncology using a limited number of cells: optimization of whole genome amplification products for sequencing applications. BMC Cancer 2017;17:457. [PMID: 28666423 DOI: 10.1186/s12885-017-3447-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
32 Pauli C, Hopkins BD, Prandi D, Shaw R, Fedrizzi T, Sboner A, Sailer V, Augello M, Puca L, Rosati R, McNary TJ, Churakova Y, Cheung C, Triscott J, Pisapia D, Rao R, Mosquera JM, Robinson B, Faltas BM, Emerling BE, Gadi VK, Bernard B, Elemento O, Beltran H, Demichelis F, Kemp CJ, Grandori C, Cantley LC, Rubin MA. Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine. Cancer Discov. 2017;7:462-477. [PMID: 28331002 DOI: 10.1158/2159-8290.cd-16-1154] [Cited by in Crossref: 389] [Cited by in F6Publishing: 251] [Article Influence: 77.8] [Reference Citation Analysis]
33 Chen Y, Li G, Liu ML. Microvesicles as Emerging Biomarkers and Therapeutic Targets in Cardiometabolic Diseases. Genomics Proteomics Bioinformatics 2018;16:50-62. [PMID: 29462670 DOI: 10.1016/j.gpb.2017.03.006] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 15.5] [Reference Citation Analysis]
34 Venniyoor A. The most important questions in cancer research and clinical oncology-Question 2-5. Obesity-related cancers: more questions than answers. Chin J Cancer 2017;36:18. [PMID: 28143590 DOI: 10.1186/s40880-017-0185-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
35 Yasui H, Kobayashi M, Sato K, Kondoh K, Ishida T, Kaito Y, Tamura H, Handa H, Tsukune Y, Sasaki M, Komatsu N, Tanaka N, Tanaka J, Kizaki M, Kawamata T, Makiyama J, Yokoyama K, Imoto S, Tojo A, Imai Y. Circulating cell-free DNA in the peripheral blood plasma of patients is an informative biomarker for multiple myeloma relapse. Int J Clin Oncol 2021. [PMID: 34259983 DOI: 10.1007/s10147-021-01991-z] [Reference Citation Analysis]
36 Liao X, Zhao L, Wu S, Zheng H, Chen H, Zhang H, Wang Z, Lin Q. Microsatellite stability and mismatch repair proficiency in nasopharyngeal carcinoma may not predict programmed death-1 blockade resistance. Oncotarget 2017;8:113287-93. [PMID: 29348907 DOI: 10.18632/oncotarget.22938] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
37 Lee HO, Park WY. Single Cell Genomics for Tumor Heterogeneity. Adv Exp Med Biol 2021;1187:205-14. [PMID: 33983580 DOI: 10.1007/978-981-32-9620-6_10] [Reference Citation Analysis]
38 Mastoraki S, Balgkouranidou I, Tsaroucha E, Klinakis A, Georgoulias V, Lianidou E. KMT2C promoter methylation in plasma-circulating tumor DNA is a prognostic biomarker in non-small cell lung cancer. Mol Oncol 2021;15:2412-22. [PMID: 33159839 DOI: 10.1002/1878-0261.12848] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
39 Salvianti F, Canu L, Poli G, Armignacco R, Scatena C, Cantini G, Di Franco A, Gelmini S, Ercolino T, Pazzagli M, Nesi G, Mannelli M, Pinzani P, Luconi M. New insights in the clinical and translational relevance of miR483-5p in adrenocortical cancer. Oncotarget 2017;8:65525-33. [PMID: 29029450 DOI: 10.18632/oncotarget.19118] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
40 Miao X, Fang Q, Xiao X, Liu S, Wu R, Yan J, Nie B, Liu J. Integrating Cycled Enzymatic DNA Amplification and Surface-Enhanced Raman Scattering for Sensitive Detection of Circulating Tumor DNA. Front Mol Biosci 2021;8:676065. [PMID: 34017856 DOI: 10.3389/fmolb.2021.676065] [Reference Citation Analysis]
41 Dhawan A. Extracellular miRNA biomarkers in neurologic disease: is cerebrospinal fluid helpful? Biomark Med 2021;15:1377-88. [PMID: 34514843 DOI: 10.2217/bmm-2021-0092] [Reference Citation Analysis]
42 Gallerani G, Fabbri F. Circulating Tumor Cells in the Adenocarcinoma of the Esophagus. Int J Mol Sci 2016;17:E1266. [PMID: 27527155 DOI: 10.3390/ijms17081266] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
43 Agashe R, Kurzrock R. Circulating Tumor Cells: From the Laboratory to the Cancer Clinic. Cancers (Basel) 2020;12:E2361. [PMID: 32825548 DOI: 10.3390/cancers12092361] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
44 Ferreira D, Miranda J, Martins-Lopes P, Adega F, Chaves R. Future Perspectives in Detecting EGFR and ALK Gene Alterations in Liquid Biopsies of Patients with NSCLC. Int J Mol Sci 2021;22:3815. [PMID: 33916986 DOI: 10.3390/ijms22083815] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Miao Z, Mu T, Liu L, Rao J, Jin M, Wang Z, Wang H, Lu C, Gong X, Zheng D, Zheng D, Li X, Li Y, Chen S, Shu X. Case Report: A Chronological Combination Treatment of Icotinib, Osimertinib, and Crizotinib on Lung Adenocarcinoma Guided by Serial Genetic Tests of Circulating Tumor DNA and Sediment Cell Genomic DNA From Pleural Effusion. Front Oncol 2020;10:561341. [PMID: 33194628 DOI: 10.3389/fonc.2020.561341] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 El Hachem G, Gombos A, Awada A. Recent advances in understanding breast cancer and emerging therapies with a focus on luminal and triple-negative breast cancer. F1000Res 2019;8:F1000 Faculty Rev-591. [PMID: 31069063 DOI: 10.12688/f1000research.17542.1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
47 Guerrini L, Alvarez-Puebla RA. Surface-Enhanced Raman Spectroscopy in Cancer Diagnosis, Prognosis and Monitoring. Cancers (Basel) 2019;11:E748. [PMID: 31146464 DOI: 10.3390/cancers11060748] [Cited by in Crossref: 33] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
48 Voss T, Ullius A, Schönborn M, Oelmüller U. Sensitivity assessment of workflows detecting rare circulating cell-free DNA targets: A study design proposal. PLoS One 2021;16:e0253401. [PMID: 34228726 DOI: 10.1371/journal.pone.0253401] [Reference Citation Analysis]
49 Ravegnini G, Sammarini G, Serrano C, Nannini M, Pantaleo MA, Hrelia P, Angelini S. Clinical relevance of circulating molecules in cancer: focus on gastrointestinal stromal tumors. Ther Adv Med Oncol 2019;11:1758835919831902. [PMID: 30854029 DOI: 10.1177/1758835919831902] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
50 Augestad KM, Merok MA, Ignatovic D. Tailored Treatment of Colorectal Cancer: Surgical, Molecular, and Genetic Considerations. Clin Med Insights Oncol 2017;11:1179554917690766. [PMID: 28469509 DOI: 10.1177/1179554917690766] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
51 Wolny-Rokicka E, Petrasz P, Krajewski W, Sulimiera Michalak S, Tukiendorf A. Analysis of Serum Markers with Regard to Treatment Procedures in Advanced Stage Prostate Cancer Patients. Med Sci Monit 2020;26:e925860. [PMID: 33326414 DOI: 10.12659/MSM.925860] [Reference Citation Analysis]
52 Tieng FYF, Abu N, Nasir SN, Lee LH, Ab Mutalib NS. Liquid Biopsy-Based Colorectal Cancer Screening via Surface Markers of Circulating Tumor Cells. Diagnostics (Basel) 2021;11:2136. [PMID: 34829483 DOI: 10.3390/diagnostics11112136] [Reference Citation Analysis]
53 Yang J, Cheng S, Zhang N, Jin Y, Wang Y. Liquid biopsy for ovarian cancer using circulating tumor cells: Recent advances on the path to precision medicine. Biochim Biophys Acta Rev Cancer 2021;1877:188660. [PMID: 34800546 DOI: 10.1016/j.bbcan.2021.188660] [Reference Citation Analysis]
54 Freitas MO, Gartner J, Rangel-Pozzo A, Mai S. Genomic Instability in Circulating Tumor Cells. Cancers (Basel) 2020;12:E3001. [PMID: 33081135 DOI: 10.3390/cancers12103001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
55 Mincarelli L, Lister A, Lipscombe J, Macaulay IC. Defining Cell Identity with Single-Cell Omics. Proteomics 2018;18:e1700312. [PMID: 29644800 DOI: 10.1002/pmic.201700312] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 8.5] [Reference Citation Analysis]
56 Pan L, Yan G, Chen W, Sun L, Wang J, Yang J. Distribution of circulating tumor cell phenotype in early cervical cancer. Cancer Manag Res 2019;11:5531-6. [PMID: 31354357 DOI: 10.2147/CMAR.S198391] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
57 Palmirotta R, Lovero D, Cafforio P, Felici C, Mannavola F, Pellè E, Quaresmini D, Tucci M, Silvestris F. Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology. Ther Adv Med Oncol 2018;10:1758835918794630. [PMID: 30181785 DOI: 10.1177/1758835918794630] [Cited by in Crossref: 149] [Cited by in F6Publishing: 136] [Article Influence: 37.3] [Reference Citation Analysis]
58 Kaczor-Urbanowicz KE, Martín Carreras-Presas C, Kaczor T, Tu M, Wei F, Garcia-Godoy F, Wong DT. Emerging technologies for salivaomics in cancer detection. J Cell Mol Med 2017;21:640-7. [PMID: 27862926 DOI: 10.1111/jcmm.13007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 5.8] [Reference Citation Analysis]
59 Kim TH, Wang Y, Oliver CR, Thamm DH, Cooling L, Paoletti C, Smith KJ, Nagrath S, Hayes DF. A temporary indwelling intravascular aphaeretic system for in vivo enrichment of circulating tumor cells. Nat Commun 2019;10:1478. [PMID: 30932020 DOI: 10.1038/s41467-019-09439-9] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 12.3] [Reference Citation Analysis]
60 Li F, Wei F, Huang WL, Lin CC, Li L, Shen MM, Yan Q, Liao W, Chia D, Tu M, Tang JH, Feng Z, Kim Y, Su WC, Wong DTW. Ultra-Short Circulating Tumor DNA (usctDNA) in Plasma and Saliva of Non-Small Cell Lung Cancer (NSCLC) Patients. Cancers (Basel) 2020;12:E2041. [PMID: 32722209 DOI: 10.3390/cancers12082041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
61 Jensen SG, Epistolio S, Madsen CL, Kyneb MH, Riva A, Paganotti A, Barizzi J, Petersen RK, Børgesen M, Molinari F, Boldorini R, Lorenzen J, Sørensen E, Christensen UB, Høgdall E, Frattini M. A new sensitive and fast assay for the detection of EGFR mutations in liquid biopsies. PLoS One 2021;16:e0253687. [PMID: 34166445 DOI: 10.1371/journal.pone.0253687] [Reference Citation Analysis]
62 Bushnell GG, Hong X, Hartfield RM, Zhang Y, Oakes RS, Rao SS, Jeruss JS, Stegemann JP, Deng CX, Shea LD. High Frequency Spectral Ultrasound Imaging to Detect Metastasis in Implanted Biomaterial Scaffolds. Ann Biomed Eng 2020;48:477-89. [PMID: 31549327 DOI: 10.1007/s10439-019-02366-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
63 Denis JA, Guillerm E, Coulet F, Larsen AK, Lacorte JM. The Role of BEAMing and Digital PCR for Multiplexed Analysis in Molecular Oncology in the Era of Next-Generation Sequencing. Mol Diagn Ther 2017;21:587-600. [PMID: 28667577 DOI: 10.1007/s40291-017-0287-7] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
64 Bushnell GG, Hardas TP, Hartfield RM, Zhang Y, Oakes RS, Ronquist S, Chen H, Rajapakse I, Wicha MS, Jeruss JS, Shea LD. Biomaterial Scaffolds Recruit an Aggressive Population of Metastatic Tumor Cells In Vivo. Cancer Res 2019;79:2042-53. [PMID: 30808673 DOI: 10.1158/0008-5472.CAN-18-2502] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 4.7] [Reference Citation Analysis]
65 Schreier S, Budchart P, Borwornpinyo S, Arpornwirat W, Triampo W. Circulating erythroblast abnormality associated with systemic pathologies may indicate bone marrow damage. J Circ Biomark 2021;10:14-9. [PMID: 34694303 DOI: 10.33393/jcb.2021.2220] [Reference Citation Analysis]
66 Marsavela G, Johansson PA, Pereira MR, McEvoy AC, Reid AL, Robinson C, Warburton L, Khattak MA, Meniawy TM, Amanuel B, Millward M, Hayward NK, Ziman MR, Gray ES, Calapre L. The Prognostic Impact of Circulating Tumour DNA in Melanoma Patients Treated with Systemic Therapies-Beyond BRAF Mutant Detection. Cancers (Basel) 2020;12:E3793. [PMID: 33339135 DOI: 10.3390/cancers12123793] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
67 Pantel K, Alix-Panabières C. Liquid biopsy in 2016: Circulating tumour cells and cell-free DNA in gastrointestinal cancer. Nat Rev Gastroenterol Hepatol 2017;14:73-4. [PMID: 28096542 DOI: 10.1038/nrgastro.2016.198] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
68 Marrugo-Ramírez J, Mir M, Samitier J. Blood-Based Cancer Biomarkers in Liquid Biopsy: A Promising Non-Invasive Alternative to Tissue Biopsy. Int J Mol Sci 2018;19:E2877. [PMID: 30248975 DOI: 10.3390/ijms19102877] [Cited by in Crossref: 121] [Cited by in F6Publishing: 100] [Article Influence: 30.3] [Reference Citation Analysis]
69 Chen Q, Yao L, Burner D, Minev B, Lu L, Wang M, Ma W. Epithelial membrane protein 2: a novel biomarker for circulating tumor cell recovery in breast cancer. Clin Transl Oncol 2019;21:433-42. [PMID: 30218306 DOI: 10.1007/s12094-018-1941-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
70 Abreu M, Cabezas-Sainz P, Alonso-Alconada L, Ferreirós A, Mondelo-Macía P, Lago-Lestón RM, Abalo A, Díaz E, Palacios-Zambrano S, Rojo-Sebastian A, López-López R, Sánchez L, Moreno-Bueno G, Muinelo-Romay L. Circulating Tumor Cells Characterization Revealed TIMP1 as a Potential Therapeutic Target in Ovarian Cancer. Cells 2020;9:E1218. [PMID: 32423054 DOI: 10.3390/cells9051218] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
71 Po JW, Ma Y, Balakrishna B, Brungs D, Azimi F, de Souza P, Becker TM. Immunomagnetic isolation of circulating melanoma cells and detection of PD-L1 status. PLoS One 2019;14:e0211866. [PMID: 30735560 DOI: 10.1371/journal.pone.0211866] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
72 Ulz P, Perakis S, Zhou Q, Moser T, Belic J, Lazzeri I, Wölfler A, Zebisch A, Gerger A, Pristauz G, Petru E, White B, Roberts CES, John JS, Schimek MG, Geigl JB, Bauernhofer T, Sill H, Bock C, Heitzer E, Speicher MR. Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection. Nat Commun 2019;10:4666. [PMID: 31604930 DOI: 10.1038/s41467-019-12714-4] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 13.3] [Reference Citation Analysis]
73 Nordgård O, Brendsdal Forthun R, Lapin M, Grønberg BH, Kalland KH, Kopperud RK, Thomsen LCV, Tjensvoll K, Gilje B, Gjertsen BT, Hovland R. Liquid Biopsies in Solid Cancers: Implementation in a Nordic Healthcare System. Cancers (Basel) 2021;13:1861. [PMID: 33924696 DOI: 10.3390/cancers13081861] [Reference Citation Analysis]
74 Ou CY, Vu T, Grunwald JT, Toledano M, Zimak J, Toosky M, Shen B, Zell JA, Gratton E, Abram TJ, Zhao W. An ultrasensitive test for profiling circulating tumor DNA using integrated comprehensive droplet digital detection. Lab Chip 2019;19:993-1005. [PMID: 30735225 DOI: 10.1039/c8lc01399c] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
75 Tellez-Gabriel M, Brown HK, Young R, Heymann MF, Heymann D. The Challenges of Detecting Circulating Tumor Cells in Sarcoma. Front Oncol 2016;6:202. [PMID: 27656422 DOI: 10.3389/fonc.2016.00202] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
76 Sassu CM, Palaia I, Boccia SM, Caruso G, Perniola G, Tomao F, Di Donato V, Musella A, Muzii L. Role of Circulating Biomarkers in Platinum-Resistant Ovarian Cancer. Int J Mol Sci 2021;22:13650. [PMID: 34948446 DOI: 10.3390/ijms222413650] [Reference Citation Analysis]
77 Bankaitis K, Borriello L, Cox T, Lynch C, Zijlstra A, Fingleton B, Gužvić M, Anderson R, Neman J. Meeting report: Metastasis Research Society-Chinese Tumor Metastasis Society joint conference on metastasis. Clin Exp Metastasis 2017;34:203-13. [PMID: 28260197 DOI: 10.1007/s10585-017-9842-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
78 Osumi H, Shinozaki E, Takeda Y, Wakatsuki T, Ichimura T, Saiura A, Yamaguchi K, Takahashi S, Noda T, Zembutsu H. Clinical relevance of circulating tumor DNA assessed through deep sequencing in patients with metastatic colorectal cancer. Cancer Med. 2019;8:408-417. [PMID: 30575318 DOI: 10.1002/cam4.1913] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
79 Rizzo A, Ricci AD, Tavolari S, Brandi G. Circulating Tumor DNA in Biliary Tract Cancer: Current Evidence and Future Perspectives. Cancer Genomics Proteomics. 2020;17:441-452. [PMID: 32859625 DOI: 10.21873/cgp.20203] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 38.0] [Reference Citation Analysis]
80 Quandt D, Dieter Zucht H, Amann A, Wulf-Goldenberg A, Borrebaeck C, Cannarile M, Lambrechts D, Oberacher H, Garrett J, Nayak T, Kazinski M, Massie C, Schwarzenbach H, Maio M, Prins R, Wendik B, Hockett R, Enderle D, Noerholm M, Hendriks H, Zwierzina H, Seliger B. Implementing liquid biopsies into clinical decision making for cancer immunotherapy. Oncotarget 2017;8:48507-20. [PMID: 28501851 DOI: 10.18632/oncotarget.17397] [Cited by in Crossref: 44] [Cited by in F6Publishing: 37] [Article Influence: 11.0] [Reference Citation Analysis]
81 Nonaka T, Wong DTW. Liquid Biopsy in Head and Neck Cancer: Promises and Challenges. J Dent Res 2018;97:701-8. [PMID: 29513618 DOI: 10.1177/0022034518762071] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 10.5] [Reference Citation Analysis]
82 Smit DJ, Cayrefourcq L, Haider MT, Hinz N, Pantel K, Alix-Panabières C, Jücker M. High Sensitivity of Circulating Tumor Cells Derived from a Colorectal Cancer Patient for Dual Inhibition with AKT and mTOR Inhibitors. Cells 2020;9:E2129. [PMID: 32962206 DOI: 10.3390/cells9092129] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
83 Rashdan S, Iyengar P, Minna JD, Gerber DE. Narrative review: molecular and genetic profiling of oligometastatic non-small cell lung cancer. Transl Lung Cancer Res 2021;10:3351-68. [PMID: 34430372 DOI: 10.21037/tlcr-21-448] [Reference Citation Analysis]
84 Mari R, Mamessier E, Lambaudie E, Provansal M, Birnbaum D, Bertucci F, Sabatier R. Liquid Biopsies for Ovarian Carcinoma: How Blood Tests May Improve the Clinical Management of a Deadly Disease. Cancers (Basel) 2019;11:E774. [PMID: 31167492 DOI: 10.3390/cancers11060774] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
85 Tanaka J, Nakagawa T, Shiratori A, Shimazaki Y, Uematsu C, Kamahori M, Yokoi T, Harada K, Kohara Y. KRAS genotyping by digital PCR combined with melting curve analysis. Sci Rep 2019;9:2626. [PMID: 30796246 DOI: 10.1038/s41598-019-38822-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
86 Iliescu FS, Poenar DP, Yu F, Ni M, Chan KH, Cima I, Taylor HK, Cima I, Iliescu C. Recent advances in microfluidic methods in cancer liquid biopsy. Biomicrofluidics 2019;13:041503. [PMID: 31431816 DOI: 10.1063/1.5087690] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
87 Riethdorf S, Soave A, Rink M. The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer. Transl Androl Urol 2017;6:1090-110. [PMID: 29354496 DOI: 10.21037/tau.2017.09.16] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
88 Tseng CP, Leong KK, Liou MJ, Hsu HL, Lin HC, Chen YA, Lin JD. Circulating epithelial cell counts for monitoring the therapeutic outcome of patients with papillary thyroid carcinoma. Oncotarget 2017;8:77453-64. [PMID: 29100400 DOI: 10.18632/oncotarget.20512] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
89 Gordon-Rodriguez E, Quinn TP, Cunningham JP. Learning Sparse Log-Ratios for High-Throughput Sequencing Data. Bioinformatics 2021:btab645. [PMID: 34498030 DOI: 10.1093/bioinformatics/btab645] [Reference Citation Analysis]
90 Tibdewal A, Agarwal JP, Srinivasan S, Mummudi N, Noronha V, Prabhash K, Patil V, Purandare N, Janu A, Kannan S. Standard maintenance therapy versus local consolidative radiation therapy and standard maintenance therapy in 1-5 sites of oligometastatic non-small cell lung cancer: a study protocol of phase III randomised controlled trial. BMJ Open 2021;11:e043628. [PMID: 33727268 DOI: 10.1136/bmjopen-2020-043628] [Reference Citation Analysis]
91 Herrera AF, Armand P. Minimal Residual Disease Assessment in Lymphoma: Methods and Applications. J Clin Oncol 2017;35:3877-87. [PMID: 28933999 DOI: 10.1200/JCO.2017.74.5281] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 4.4] [Reference Citation Analysis]
92 Müller Bark J, Kulasinghe A, Hartel G, Leo P, Warkiani ME, Jeffree RL, Chua B, Day BW, Punyadeera C. Isolation of Circulating Tumour Cells in Patients With Glioblastoma Using Spiral Microfluidic Technology - A Pilot Study. Front Oncol 2021;11:681130. [PMID: 34150645 DOI: 10.3389/fonc.2021.681130] [Reference Citation Analysis]
93 Zhou Y, Xia L, Lin J, Wang H, Oyang L, Tan S, Tian Y, Su M, Wang H, Cao D, Liao Q. Exosomes in Nasopharyngeal Carcinoma. J Cancer 2018;9:767-77. [PMID: 29581754 DOI: 10.7150/jca.22505] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
94 Zhang Y, Mi X, Tan X, Xiang R. Recent Progress on Liquid Biopsy Analysis using Surface-Enhanced Raman Spectroscopy. Theranostics 2019;9:491-525. [PMID: 30809289 DOI: 10.7150/thno.29875] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 13.3] [Reference Citation Analysis]
95 Torrano V, Royo F, Peinado H, Loizaga-Iriarte A, Unda M, Falcón-Perez JM, Carracedo A. Vesicle-MaNiA: extracellular vesicles in liquid biopsy and cancer. Curr Opin Pharmacol 2016;29:47-53. [PMID: 27366992 DOI: 10.1016/j.coph.2016.06.003] [Cited by in Crossref: 41] [Cited by in F6Publishing: 37] [Article Influence: 6.8] [Reference Citation Analysis]
96 Selvarajah S, Plante S, Speevak M, Vaags A, Hamelinck D, Butcher M, McCready E, Grafodatskaya D, Blais N, Tran-Thanh D, Weng X, Nassabein R, Greer W, Walton RN, Lo B, Demetrick D, Santos S, Sadikovic B, Zhang X, Zhang T, Spence T, Stockley T, Feilotter H, Joubert P. A Pan-Canadian Validation Study for the Detection of EGFR T790M Mutation Using Circulating Tumor DNA From Peripheral Blood. JTO Clin Res Rep 2021;2:100212. [PMID: 34590051 DOI: 10.1016/j.jtocrr.2021.100212] [Reference Citation Analysis]
97 Poulet G, Garlan F, Garrigou S, Zonta E, Benhaim L, Carrillon MJ, Didelot A, Le Corre D, Mulot C, Nizard P, Ginot F, Boutonnet-Rodat A, Blons H, Bachet JB, Taïeb J, Zaanan A, Geromel V, Pellegrina L, Laurent-Puig P, Wang-Renault SF, Taly V. Characterization of Plasma Cell-Free DNA Integrity Using Droplet-Based Digital PCR: Toward the Development of Circulating Tumor DNA-Dedicated Assays. Front Oncol 2021;11:639675. [PMID: 34094923 DOI: 10.3389/fonc.2021.639675] [Reference Citation Analysis]
98 Velcheti V, Pennell NA. Non-invasive diagnostic platforms in management of non-small cell lung cancer: opportunities and challenges. Ann Transl Med 2017;5:378. [PMID: 29057238 DOI: 10.21037/atm.2017.08.24] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
99 Jung D, Jain P, Yao Y, Wang M. Advances in the assessment of minimal residual disease in mantle cell lymphoma. J Hematol Oncol 2020;13:127. [PMID: 32972438 DOI: 10.1186/s13045-020-00961-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
100 Yue C, Jiang Y, Li P, Wang Y, Xue J, Li N, Li D, Wang R, Dang Y, Hu Z, Yang Y, Xu J. Dynamic change of PD-L1 expression on circulating tumor cells in advanced solid tumor patients undergoing PD-1 blockade therapy. Oncoimmunology 2018;7:e1438111. [PMID: 29900038 DOI: 10.1080/2162402X.2018.1438111] [Cited by in Crossref: 58] [Cited by in F6Publishing: 49] [Article Influence: 14.5] [Reference Citation Analysis]
101 Yoo TK. Liquid Biopsy in Breast Cancer: Circulating Tumor Cells and Circulating Tumor DNA. Adv Exp Med Biol 2021;1187:337-61. [PMID: 33983587 DOI: 10.1007/978-981-32-9620-6_17] [Reference Citation Analysis]
102 Blomain ES, Moding EJ. Liquid Biopsies for Molecular Biology-Based Radiotherapy. Int J Mol Sci 2021;22:11267. [PMID: 34681925 DOI: 10.3390/ijms222011267] [Reference Citation Analysis]
103 Zhang L, Liang Y, Li S, Zeng F, Meng Y, Chen Z, Liu S, Tao Y, Yu F. The interplay of circulating tumor DNA and chromatin modification, therapeutic resistance, and metastasis. Mol Cancer 2019;18:36. [PMID: 30849971 DOI: 10.1186/s12943-019-0989-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
104 Alix-Panabières C, Pantel K. Liquid biopsy: from discovery to clinical implementation. Mol Oncol 2021;15:1617-21. [PMID: 34075709 DOI: 10.1002/1878-0261.12997] [Reference Citation Analysis]
105 Tellez-Gabriel M, Cochonneau D, Cadé M, Jubellin C, Heymann MF, Heymann D. Circulating Tumor Cell-Derived Pre-Clinical Models for Personalized Medicine. Cancers (Basel) 2018;11:E19. [PMID: 30586936 DOI: 10.3390/cancers11010019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 4.3] [Reference Citation Analysis]
106 Panagopoulou M, Cheretaki A, Karaglani M, Balgkouranidou I, Biziota E, Amarantidis K, Xenidis N, Kakolyris S, Baritaki S, Chatzaki E. Methylation Status of Corticotropin-Releasing Factor (CRF) Receptor Genes in Colorectal Cancer. J Clin Med 2021;10:2680. [PMID: 34207031 DOI: 10.3390/jcm10122680] [Reference Citation Analysis]
107 Yang B, Feng X, Liu H, Tong R, Wu J, Li C, Yu H, Chen Y, Cheng Q, Chen J, Cai X, Wu W, Lu Y, Hu J, Liang K, Lv Z, Zheng S. High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma. Oncogene. 2020;39:6529-6543. [PMID: 32917956 DOI: 10.1038/s41388-020-01450-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]
108 Aghamir SMK, Heshmat R, Ebrahimi M, Khatami F. Liquid Biopsy: The Unique Test for Chasing the Genetics of Solid Tumors. Epigenet Insights 2020;13:2516865720904052. [PMID: 32166219 DOI: 10.1177/2516865720904052] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
109 Openshaw MR, McVeigh TP. Non-invasive Technology Advances in Cancer-A Review of the Advances in the Liquid Biopsy for Endometrial and Ovarian Cancers. Front Digit Health 2020;2:573010. [PMID: 34713045 DOI: 10.3389/fdgth.2020.573010] [Reference Citation Analysis]
110 Fasanya HO, Dopico PJ, Yeager Z, Fan ZH, Siemann DW. Using a combination of gangliosides and cell surface vimentin as surface biomarkers for isolating osteosarcoma cells in microfluidic devices. J Bone Oncol 2021;28:100357. [PMID: 33912384 DOI: 10.1016/j.jbo.2021.100357] [Reference Citation Analysis]
111 Trigg RM, Martinson LJ, Parpart-Li S, Shaw JA. Factors that influence quality and yield of circulating-free DNA: A systematic review of the methodology literature. Heliyon 2018;4:e00699. [PMID: 30094369 DOI: 10.1016/j.heliyon.2018.e00699] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 11.3] [Reference Citation Analysis]
112 Yamamoto H, Watanabe Y, Sato Y, Maehata T, Itoh F. Non-Invasive Early Molecular Detection of Gastric Cancers. Cancers (Basel) 2020;12:E2880. [PMID: 33036473 DOI: 10.3390/cancers12102880] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
113 Liu C, Xiang X, Han S, Lim HY, Li L, Zhang X, Ma Z, Yang L, Guo S, Soo R, Ren B, Wang L, Goh BC. Blood-based liquid biopsy: Insights into early detection and clinical management of lung cancer. Cancer Lett 2022;524:91-102. [PMID: 34656690 DOI: 10.1016/j.canlet.2021.10.013] [Reference Citation Analysis]
114 Tabor S, Szostakowska-Rodzos M, Fabisiewicz A, Grzybowska EA. How to Predict Metastasis in Luminal Breast Cancer? Current Solutions and Future Prospects. Int J Mol Sci 2020;21:E8415. [PMID: 33182512 DOI: 10.3390/ijms21218415] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
115 Yadavalli S, Jayaram S, Manda SS, Madugundu AK, Nayakanti DS, Tan TZ, Bhat R, Rangarajan A, Chatterjee A, Gowda H, Thiery JP, Kumar P. Data-Driven Discovery of Extravasation Pathway in Circulating Tumor Cells. Sci Rep. 2017;7:43710. [PMID: 28262832 DOI: 10.1038/srep43710] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
116 Cayrefourcq L, De Roeck A, Garcia C, Stoebner PE, Fichel F, Garima F, Perriard F, Daures JP, Meunier L, Alix-Panabières C. S100-EPISPOT: A New Tool to Detect Viable Circulating Melanoma Cells. Cells 2019;8:E755. [PMID: 31330795 DOI: 10.3390/cells8070755] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
117 Heeke S, Mograbi B, Alix-Panabières C, Hofman P. Never Travel Alone: The Crosstalk of Circulating Tumor Cells and the Blood Microenvironment. Cells 2019;8:E714. [PMID: 31337010 DOI: 10.3390/cells8070714] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 11.0] [Reference Citation Analysis]
118 Zhu J, Chen S, Zhang F, Wang L. Cell-Free eccDNAs: A New Type of Nucleic Acid Component for Liquid Biopsy? Mol Diagn Ther 2018;22:515-22. [PMID: 29959693 DOI: 10.1007/s40291-018-0348-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
119 Anand K, Roszik J, Gombos D, Upshaw J, Sarli V, Meas S, Lucci A, Hall C, Patel S. Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma. Cancers (Basel) 2019;11:E856. [PMID: 31226786 DOI: 10.3390/cancers11060856] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
120 Li Y, Tian X, Gao L, Jiang X, Fu R, Zhang T, Ren T, Hu P, Wu Y, Zhao P, Yang D. Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer. Cancer Med 2019;8:3782-92. [PMID: 31132233 DOI: 10.1002/cam4.2286] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
121 Mroz EA, Rocco JW. The challenges of tumor genetic diversity. Cancer 2017;123:917-27. [PMID: 27861749 DOI: 10.1002/cncr.30430] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 5.2] [Reference Citation Analysis]
122 Perakis S, Speicher MR. Emerging concepts in liquid biopsies. BMC Med 2017;15:75. [PMID: 28381299 DOI: 10.1186/s12916-017-0840-6] [Cited by in Crossref: 121] [Cited by in F6Publishing: 113] [Article Influence: 24.2] [Reference Citation Analysis]
123 Lodewijk I, Dueñas M, Rubio C, Munera-Maravilla E, Segovia C, Bernardini A, Teijeira A, Paramio JM, Suárez-Cabrera C. Liquid Biopsy Biomarkers in Bladder Cancer: A Current Need for Patient Diagnosis and Monitoring. Int J Mol Sci 2018;19:E2514. [PMID: 30149597 DOI: 10.3390/ijms19092514] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 7.5] [Reference Citation Analysis]
124 Vishwakarma R, McManus KJ. Chromosome Instability; Implications in Cancer Development, Progression, and Clinical Outcomes. Cancers (Basel). 2020;1 2:824. [PMID: 32235397 DOI: 10.3390/cancers12040824] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
125 Huang HM, Li HX. Tumor heterogeneity and the potential role of liquid biopsy in bladder cancer. Cancer Commun (Lond) 2021;41:91-108. [PMID: 33377623 DOI: 10.1002/cac2.12129] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
126 Müller Bark J, Kulasinghe A, Chua B, Day BW, Punyadeera C. Circulating biomarkers in patients with glioblastoma. Br J Cancer 2020;122:295-305. [PMID: 31666668 DOI: 10.1038/s41416-019-0603-6] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 15.0] [Reference Citation Analysis]
127 Schneegans S, Lück L, Besler K, Bluhm L, Stadler JC, Staub J, Greinert R, Volkmer B, Kubista M, Gebhardt C, Sartori A, Irwin D, Serkkola E, Af Hällström T, Lianidou E, Sprenger-Haussels M, Hussong M, Mohr P, Schneider SW, Shaffer J, Pantel K, Wikman H. Pre-analytical factors affecting the establishment of a single tube assay for multiparameter liquid biopsy detection in melanoma patients. Mol Oncol 2020;14:1001-15. [PMID: 32246814 DOI: 10.1002/1878-0261.12669] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
128 Salvianti F, Gelmini S, Mancini I, Pazzagli M, Pillozzi S, Giommoni E, Brugia M, Di Costanzo F, Galardi F, De Luca F, Castiglione F, Messerini L, Pinzani P, Antonuzzo L. Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study. Br J Cancer 2021;125:94-100. [PMID: 33953347 DOI: 10.1038/s41416-021-01399-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
129 Pal A, Shinde R, Miralles MS, Workman P, de Bono J. Applications of liquid biopsy in the Pharmacological Audit Trail for anticancer drug development. Nat Rev Clin Oncol 2021;18:454-67. [PMID: 33762744 DOI: 10.1038/s41571-021-00489-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
130 Harada K, Mizrak Kaya D, Shimodaira Y, Song S, Baba H, Ajani JA. Translating genomic profiling to gastrointestinal cancer treatment. Future Oncol 2017;13:919-34. [PMID: 28067073 DOI: 10.2217/fon-2016-0422] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
131 Rampazzo E, Del Bianco P, Bertorelle R, Boso C, Perin A, Spiro G, Bergamo F, Belluco C, Buonadonna A, Palazzari E, Lonardi S, De Paoli A, Pucciarelli S, De Rossi A. The predictive and prognostic potential of plasma telomerase reverse transcriptase (TERT) RNA in rectal cancer patients. Br J Cancer 2018;118:878-86. [PMID: 29449673 DOI: 10.1038/bjc.2017.492] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
132 Freitas AJA, Causin RL, Varuzza MB, Hidalgo Filho CMT, Silva VDD, Souza CP, Marques MMC. Molecular Biomarkers Predict Pathological Complete Response of Neoadjuvant Chemotherapy in Breast Cancer Patients: Review. Cancers (Basel) 2021;13:5477. [PMID: 34771640 DOI: 10.3390/cancers13215477] [Reference Citation Analysis]
133 Patel D, Chan D, Cehic G, Pavlakis N, Price TJ. Systemic therapies for advanced gastroenteropancreatic neuroendocrine tumors. Expert Rev Endocrinol Metab 2016;11:311-27. [PMID: 30058926 DOI: 10.1080/17446651.2016.1199952] [Reference Citation Analysis]
134 Szczepanik A, Sierzega M, Drabik G, Pituch-Noworolska A, Kołodziejczyk P, Zembala M. CD44+ cytokeratin-positive tumor cells in blood and bone marrow are associated with poor prognosis of patients with gastric cancer.Gastric Cancer. 2019;22:264-272. [PMID: 30056567 DOI: 10.1007/s10120-018-0858-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
135 Long-Mira E, Ilie M, Chamorey E, Leduff-Blanc F, Montaudié H, Tanga V, Allégra M, Lespinet-Fabre V, Bordone O, Bonnetaud C, Schiappa R, Butori C, Bence C, Lacour JP, Hofman V, Hofman P. Monitoring BRAF and NRAS mutations with cell-free circulating tumor DNA from metastatic melanoma patients. Oncotarget 2018;9:36238-49. [PMID: 30546839 DOI: 10.18632/oncotarget.26343] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 3.5] [Reference Citation Analysis]
136 Osumi H, Shinozaki E, Yamaguchi K, Zembutsu H. Early change in circulating tumor DNA as a potential predictor of response to chemotherapy in patients with metastatic colorectal cancer. Sci Rep 2019;9:17358. [PMID: 31758080 DOI: 10.1038/s41598-019-53711-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
137 Boesch M, Sopper S, Zeimet AG, Reimer D, Gastl G, Ludewig B, Wolf D. Heterogeneity of Cancer Stem Cells: Rationale for Targeting the Stem Cell Niche. Biochim Biophys Acta. 2016;1866:276-289. [PMID: 27751894 DOI: 10.1016/j.bbcan.2016.10.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
138 Wei J, Liu X, Li T, Xing P, Zhang C, Yang J. The new horizon of liquid biopsy in sarcoma: the potential utility of circulating tumor nucleic acids. J Cancer 2020;11:5293-308. [PMID: 32742476 DOI: 10.7150/jca.42816] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
139 Tsai WS, Hung TF, Chen JY, Huang SH, Chang YC. Early Detection and Dynamic Changes of Circulating Tumor Cells in Transgenic NeuN Transgenic (NTTg) Mice with Spontaneous Breast Tumor Development. Cancers (Basel) 2021;13:3294. [PMID: 34209279 DOI: 10.3390/cancers13133294] [Reference Citation Analysis]
140 Rycaj K, Li H, Zhou J, Chen X, Tang DG. Cellular determinants and microenvironmental regulation of prostate cancer metastasis. Semin Cancer Biol 2017;44:83-97. [PMID: 28408152 DOI: 10.1016/j.semcancer.2017.03.009] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 4.4] [Reference Citation Analysis]
141 Verkhovskii RA, Kozlova AA, Sindeeva OA, Kozhevnikov IO, Prikhozhdenko ES, Mayorova OA, Grishin OV, Makarkin MA, Ermakov AV, Abdurashitov AS, Tuchin VV, Bratashov DN. Lightsheet-based flow cytometer for whole blood with the ability for the magnetic retrieval of objects from the blood flow. Biomed Opt Express 2021;12:380-94. [PMID: 33659080 DOI: 10.1364/BOE.413845] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
142 Chang DY, Ma WL, Lu YS. Role of Alpelisib in the Treatment of PIK3CA-Mutated Breast Cancer: Patient Selection and Clinical Perspectives. Ther Clin Risk Manag 2021;17:193-207. [PMID: 33707948 DOI: 10.2147/TCRM.S251668] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
143 Cirillo PDR, Margiotti K, Fabiani M, Barros-Filho MC, Sparacino D, Cima A, Longo SA, Cupellaro M, Mesoraca A, Giorlandino C. Multi-analytical test based on serum miRNAs and proteins quantification for ovarian cancer early detection. PLoS One 2021;16:e0255804. [PMID: 34352040 DOI: 10.1371/journal.pone.0255804] [Reference Citation Analysis]
144 Morris RJ. Circulating tumor cells: quintessential precision oncology presenting challenges for biology. NPJ Precis Oncol 2017;1:16. [PMID: 29872703 DOI: 10.1038/s41698-017-0019-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
145 Purcell E, Owen S, Prantzalos E, Radomski A, Carman N, Lo TW, Zeinali M, Subramanian C, Ramnath N, Nagrath S. Epidermal Growth Factor Receptor Mutations Carried in Extracellular Vesicle-Derived Cargo Mirror Disease Status in Metastatic Non-small Cell Lung Cancer. Front Cell Dev Biol 2021;9:724389. [PMID: 34692681 DOI: 10.3389/fcell.2021.724389] [Reference Citation Analysis]
146 Osumi H, Shinozaki E, Ooki A, Shimozaki K, Kamiimabeppu D, Nakayama I, Wakatsuki T, Ogura M, Takahari D, Chin K, Yamaguchi K. Correlation between circulating tumor DNA and carcinoembryonic antigen levels in patients with metastatic colorectal cancer. Cancer Med 2021;10:8820-8. [PMID: 34821068 DOI: 10.1002/cam4.4384] [Reference Citation Analysis]
147 Li Y, Zhang X, Gong J, Zhang Q, Gao J, Cao Y, Wang DD, Lin PP, Shen L. Aneuploidy of chromosome 8 in circulating tumor cells correlates with prognosis in patients with advanced gastric cancer. Chin J Cancer Res 2016;28:579-88. [PMID: 28174486 DOI: 10.21147/j.issn.1000-9604.2016.06.04] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
148 Budna-Tukan J, Świerczewska M, Mazel M, Cieślikowski WA, Ida A, Jankowiak A, Antczak A, Nowicki M, Pantel K, Azria D, Zabel M, Alix-Panabières C. Analysis of Circulating Tumor Cells in Patients with Non-Metastatic High-Risk Prostate Cancer before and after Radiotherapy Using Three Different Enumeration Assays. Cancers (Basel) 2019;11:E802. [PMID: 31185699 DOI: 10.3390/cancers11060802] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
149 Xiang Z, Zou B, Zhang L, Ma X, Qi X, Wei W, Song Q, Zhou G. Ultra-sensitive and multiplex digital-PCR for quantifying the mutants in cell free DNA by employing invasive reaction as identifier. Sensors and Actuators B: Chemical 2020;320:128362. [DOI: 10.1016/j.snb.2020.128362] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
150 Wan JCM, Massie C, Garcia-Corbacho J, Mouliere F, Brenton JD, Caldas C, Pacey S, Baird R, Rosenfeld N. Liquid biopsies come of age: towards implementation of circulating tumour DNA. Nat Rev Cancer. 2017;17:223-238. [PMID: 28233803 DOI: 10.1038/nrc.2017.7] [Cited by in Crossref: 967] [Cited by in F6Publishing: 884] [Article Influence: 193.4] [Reference Citation Analysis]
151 Panagopoulou M, Karaglani M, Balgkouranidou I, Biziota E, Koukaki T, Karamitrousis E, Nena E, Tsamardinos I, Kolios G, Lianidou E, Kakolyris S, Chatzaki E. Circulating cell-free DNA in breast cancer: size profiling, levels, and methylation patterns lead to prognostic and predictive classifiers. Oncogene 2019;38:3387-401. [PMID: 30643192 DOI: 10.1038/s41388-018-0660-y] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 19.0] [Reference Citation Analysis]
152 Gao P, Lin S, Cai M, Zhu Y, Song Y, Sui Y, Lin J, Liu J, Lu X, Zhong Y, Cui Y, Zhou P. 5-Hydroxymethylcytosine profiling from genomic and cell-free DNA for colorectal cancers patients. J Cell Mol Med 2019;23:3530-7. [PMID: 30912288 DOI: 10.1111/jcmm.14252] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
153 Alix-Panabières C. The future of liquid biopsy. Nature 2020;579:S9. [PMID: 32214259 DOI: 10.1038/d41586-020-00844-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 19.0] [Reference Citation Analysis]
154 Ying S, Ke H, Ding Y, Liu Y, Tang X, Yang D, Li M, Liu J, Yu B, Xiang J, Mao X, Han-Zhang H, Hu W, Chen L. Unique genomic profiles obtained from cerebrospinal fluid cell-free DNA of non-small cell lung cancer patients with leptomeningeal metastases. Cancer Biol Ther 2019;20:562-70. [PMID: 30395779 DOI: 10.1080/15384047.2018.1538614] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 3.5] [Reference Citation Analysis]
155 Nicolazzo C, Colangelo L, Corsi A, Carpino G, Gradilone A, Sonato C, Raimondi C, Gaudio E, Gazzaniga P, Gianni W. Liquid Biopsy in Rare Cancers: Lessons from Hemangiopericytoma. Anal Cell Pathol (Amst) 2018;2018:9718585. [PMID: 29707475 DOI: 10.1155/2018/9718585] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
156 Krog BL, Henry MD. Biomechanics of the Circulating Tumor Cell Microenvironment. Adv Exp Med Biol 2018;1092:209-33. [PMID: 30368755 DOI: 10.1007/978-3-319-95294-9_11] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
157 Qiu Y, Zhang X, Deng X, Zhang R, Cai Z, Zhang Z, Liu H. Circulating tumor cell-associated white blood cell cluster is associated with poor survival of patients with gastric cancer following radical gastrectomy. Eur J Surg Oncol 2021:S0748-7983(21)00924-0. [PMID: 34836729 DOI: 10.1016/j.ejso.2021.11.115] [Reference Citation Analysis]
158 Mair R, Mouliere F. Cell-free DNA technologies for the analysis of brain cancer. Br J Cancer 2021. [PMID: 34811503 DOI: 10.1038/s41416-021-01594-5] [Reference Citation Analysis]
159 Anderson RL, Balasas T, Callaghan J, Coombes RC, Evans J, Hall JA, Kinrade S, Jones D, Jones PS, Jones R, Marshall JF, Panico MB, Shaw JA, Steeg PS, Sullivan M, Tong W, Westwell AD, Ritchie JWA; Cancer Research UK and Cancer Therapeutics CRC Australia Metastasis Working Group. A framework for the development of effective anti-metastatic agents. Nat Rev Clin Oncol. 2019;16:185-204. [PMID: 30514977 DOI: 10.1038/s41571-018-0134-8] [Cited by in Crossref: 87] [Cited by in F6Publishing: 90] [Article Influence: 29.0] [Reference Citation Analysis]
160 Jeong KY, Kim EK, Park MH, Kim HM. Perspective on Cancer Therapeutics Utilizing Analysis of Circulating Tumor Cells. Diagnostics (Basel) 2018;8:E23. [PMID: 29641512 DOI: 10.3390/diagnostics8020023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
161 Wang J, Chang S, Li G, Sun Y. Application of liquid biopsy in precision medicine: opportunities and challenges. Front Med 2017;11:522-7. [PMID: 28744793 DOI: 10.1007/s11684-017-0526-7] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 11.0] [Reference Citation Analysis]
162 Porras TB, Kaur P, Ring A, Schechter N, Lang JE. Challenges in using liquid biopsies for gene expression profiling. Oncotarget 2018;9:7036-53. [PMID: 29467948 DOI: 10.18632/oncotarget.24140] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
163 An HJ, Chon HJ, Kim C. Peripheral Blood-Based Biomarkers for Immune Checkpoint Inhibitors. Int J Mol Sci 2021;22:9414. [PMID: 34502325 DOI: 10.3390/ijms22179414] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
164 Lee SH, Lee B, Shim JH, Lee KW, Yun JW, Kim SY, Kim TY, Kim YH, Ko YH, Chung HC, Yu CS, Lee J, Rha SY, Kim TW, Jung KH, Im SA, Moon HG, Cho S, Kang JH, Kim J, Kim SK, Ryu HS, Ha SY, Kim JI, Chung YJ, Kim C, Kim HL, Park WY, Noh DY, Park K. Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients. Cancer Res Treat 2019;51:211-22. [PMID: 29690749 DOI: 10.4143/crt.2018.132] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
165 Kahyo T, Sugimura H. Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format. J Vis Exp 2018. [PMID: 30176028 DOI: 10.3791/58199] [Reference Citation Analysis]
166 Fanelli GN, Naccarato AG, Scatena C. Recent Advances in Cancer Plasticity: Cellular Mechanisms, Surveillance Strategies, and Therapeutic Optimization. Front Oncol 2020;10:569. [PMID: 32391266 DOI: 10.3389/fonc.2020.00569] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
167 Senft D, Leiserson MDM, Ruppin E, Ronai ZA. Precision Oncology: The Road Ahead. Trends Mol Med 2017;23:874-98. [PMID: 28887051 DOI: 10.1016/j.molmed.2017.08.003] [Cited by in Crossref: 73] [Cited by in F6Publishing: 57] [Article Influence: 14.6] [Reference Citation Analysis]
168 Riethdorf S, Pantel K. Liquid biopsies for surveillance and monitoring treatment response of bladder cancer. Ann Transl Med 2016;4:379. [PMID: 27826581 DOI: 10.21037/atm.2016.08.27] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
169 Koo B, Jun E, Liu H, Kim EJ, Park YY, Lim SB, Kim SC, Shin Y. A biocomposite-based rapid sampling assay for circulating cell-free DNA in liquid biopsy samples from human cancers. Sci Rep 2020;10:14932. [PMID: 32913285 DOI: 10.1038/s41598-020-72163-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
170 Rink M, Schwarzenbach H, Riethdorf S, Soave A. The current role and future directions of circulating tumor cells and circulating tumor DNA in urothelial carcinoma of the bladder. World J Urol 2019;37:1785-99. [DOI: 10.1007/s00345-018-2543-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
171 Agnoletto C, Caruso C, Garofalo C. Heterogeneous Circulating Tumor Cells in Sarcoma: Implication for Clinical Practice. Cancers (Basel) 2021;13:2189. [PMID: 34063272 DOI: 10.3390/cancers13092189] [Reference Citation Analysis]
172 Rangel-Pozzo A, Liu S, Wajnberg G, Wang X, Ouellette RJ, Hicks GG, Drachenberg D, Mai S. Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level. Cells 2020;9:E1863. [PMID: 32784507 DOI: 10.3390/cells9081863] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
173 Eslami-S Z, Cortés-Hernández LE, Alix-Panabières C. Epithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells. Cells 2020;9:E1836. [PMID: 32764280 DOI: 10.3390/cells9081836] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
174 Scharpenseel H, Hanssen A, Loges S, Mohme M, Bernreuther C, Peine S, Lamszus K, Goy Y, Petersen C, Westphal M, Glatzel M, Riethdorf S, Pantel K, Wikman H. EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients. Sci Rep 2019;9:7406. [PMID: 31092882 DOI: 10.1038/s41598-019-43678-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
175 Mussi V, Ledda M, Convertino A, Lisi A. Raman Mapping of Biological Systems Interacting with a Disordered Nanostructured Surface: A Simple and Powerful Approach to the Label-Free Analysis of Single DNA Bases. Micromachines (Basel) 2021;12:264. [PMID: 33806524 DOI: 10.3390/mi12030264] [Reference Citation Analysis]
176 Tzanikou E, Markou A, Politaki E, Koutsopoulos A, Psyrri A, Mavroudis D, Georgoulias V, Lianidou E. PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study. Mol Oncol 2019;13:2515-30. [PMID: 31254443 DOI: 10.1002/1878-0261.12540] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 8.0] [Reference Citation Analysis]
177 Witek MA, Freed IM, Soper SA. Cell Separations and Sorting. Anal Chem 2020;92:105-31. [PMID: 31808677 DOI: 10.1021/acs.analchem.9b05357] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
178 Welch DR, Hurst DR. Defining the Hallmarks of Metastasis. Cancer Res 2019;79:3011-27. [PMID: 31053634 DOI: 10.1158/0008-5472.CAN-19-0458] [Cited by in Crossref: 141] [Cited by in F6Publishing: 94] [Article Influence: 47.0] [Reference Citation Analysis]
179 Shin SH, Bode AM, Dong Z. Addressing the challenges of applying precision oncology. NPJ Precis Oncol 2017;1:28. [PMID: 29872710 DOI: 10.1038/s41698-017-0032-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
180 Bennett CW, Berchem G, Kim YJ, El-Khoury V. Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer. Oncotarget 2016;7:71013-35. [PMID: 27589834 DOI: 10.18632/oncotarget.11717] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 10.3] [Reference Citation Analysis]
181 Cho HY, Choi JH, Lim J, Lee SN, Choi JW. Microfluidic Chip-Based Cancer Diagnosis and Prediction of Relapse by Detecting Circulating Tumor Cells and Circulating Cancer Stem Cells. Cancers (Basel) 2021;13:1385. [PMID: 33803846 DOI: 10.3390/cancers13061385] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
182 Kapeleris J, Kulasinghe A, Warkiani ME, Oleary C, Vela I, Leo P, Sternes P, O'Byrne K, Punyadeera C. Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer. Transl Lung Cancer Res 2020;9:1795-809. [PMID: 33209602 DOI: 10.21037/tlcr-20-521] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
183 Pannuti A, Filipovic A, Hicks C, Lefkowitz E, Ptacek T, Stebbing J, Miele L. Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors. PLoS One 2018;13:e0194790. [PMID: 29570743 DOI: 10.1371/journal.pone.0194790] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
184 Zhu Z, Qiu S, Shao K, Hou Y. Progress and challenges of sequencing and analyzing circulating tumor cells. Cell Biol Toxicol 2018;34:405-15. [PMID: 29168077 DOI: 10.1007/s10565-017-9418-5] [Cited by in Crossref: 37] [Cited by in F6Publishing: 39] [Article Influence: 7.4] [Reference Citation Analysis]
185 Wood-Bouwens C, Lau BT, Handy CM, Lee H, Ji HP. Single-Color Digital PCR Provides High-Performance Detection of Cancer Mutations from Circulating DNA. J Mol Diagn 2017;19:697-710. [PMID: 28818432 DOI: 10.1016/j.jmoldx.2017.05.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
186 Ramirez AB, Bhat R, Sahay D, De Angelis C, Thangavel H, Hedayatpour S, Dobrolecki LE, Nardone A, Giuliano M, Nagi C, Rimawi M, Osborne CK, Lewis MT, Stilwell JL, Kaldjian EP, Schiff R, Trivedi MV. Circulating tumor cell investigation in breast cancer patient-derived xenograft models by automated immunofluorescence staining, image acquisition, and single cell retrieval and analysis. BMC Cancer 2019;19:220. [PMID: 30871481 DOI: 10.1186/s12885-019-5382-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
187 Haider MT, Ridlmaier N, Smit DJ, Taipaleenmäki H. Interleukins as Mediators of the Tumor Cell-Bone Cell Crosstalk during the Initiation of Breast Cancer Bone Metastasis. Int J Mol Sci 2021;22:2898. [PMID: 33809315 DOI: 10.3390/ijms22062898] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
188 Hwang WL, Hwang KL, Miyamoto DT. The promise of circulating tumor cells for precision cancer therapy. Biomark Med 2016;10:1269-85. [PMID: 27924634 DOI: 10.2217/bmm-2016-0192] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
189 Po JW, Ma Y, Balakrishnar B, Brungs D, Azimi F, Cooper A, Saricilar E, Murthy V, de Souza P, Becker TM. PD-L1 Detection on Circulating Melanoma Cells. Methods Mol Biol 2021;2265:223-33. [PMID: 33704718 DOI: 10.1007/978-1-0716-1205-7_17] [Reference Citation Analysis]
190 Baues M, Dasgupta A, Ehling J, Prakash J, Boor P, Tacke F, Kiessling F, Lammers T. Fibrosis imaging: Current concepts and future directions. Adv Drug Deliv Rev 2017;121:9-26. [PMID: 29108860 DOI: 10.1016/j.addr.2017.10.013] [Cited by in Crossref: 63] [Cited by in F6Publishing: 54] [Article Influence: 12.6] [Reference Citation Analysis]
191 Zhang X, Shi J, Li J, Shi X, Liu X, Zhang Y, Cui Y. Antitumor activity of everolimus in recurrent metastatic endometrial cancer with PTEN deletion: a case report. Gland Surg 2021;10:2585-90. [PMID: 34527569 DOI: 10.21037/gs-21-422] [Reference Citation Analysis]
192 Chauhan A, Kaur R, Ghoshal S, Pal A. Exploration of Circulating Tumour Cell (CTC) Biology: A Paradigm Shift in Liquid Biopsy. Indian J Clin Biochem 2021;36:131-42. [PMID: 33867703 DOI: 10.1007/s12291-020-00923-4] [Reference Citation Analysis]
193 Matikas A, Voutsina A, Trypaki M, Georgoulias V. Role of circulating free DNA in colorectal cancer. World J Gastrointest Oncol 2016; 8(12): 810-818 [PMID: 28035251 DOI: 10.4251/wjgo.v8.i12.810] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
194 Han S, Zhu W, Yang W, Guan Q, Chen C, He Q, Zhong Z, Zhao R, Xiong H, Han H, Li Y, Sun Z, Hu X, Tian J. A Prognostic Signature Constructed by CTHRC1 and LRFN4 in Stomach Adenocarcinoma. Front Genet 2021;12:646818. [PMID: 34512711 DOI: 10.3389/fgene.2021.646818] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
195 Song T, Li L, Wu S, Liu Y, Guo C, Wang W, Dai L, Zhang T, Wu H, Su B. Peripheral Blood Genetic Biomarkers for the Early Diagnosis of Hepatocellular Carcinoma. Front Oncol 2021;11:583714. [PMID: 33777736 DOI: 10.3389/fonc.2021.583714] [Reference Citation Analysis]
196 Chen J, Cao S, Situ B, Zhong J, Hu Y, Li S, Huang J, Xu J, Wu S, Lin J, Zhao Q, Cai Z, Zheng L, Wang Q. Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer. J Exp Clin Cancer Res 2018;37:127. [PMID: 29954422 DOI: 10.1186/s13046-018-0789-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 4.8] [Reference Citation Analysis]
197 Wang ZY, Wang RX, Ding XQ, Zhang X, Pan XR, Tong JH. A Protocol for Cancer-Related Mutation Detection on Exosomal DNA in Clinical Application. Front Oncol 2020;10:558106. [PMID: 33042841 DOI: 10.3389/fonc.2020.558106] [Reference Citation Analysis]
198 Wang MM, Chen C, Lynn MN, Figueiredo CR, Tan WJ, Lim TS, Coupland SE, Chan ASY. Applying Single-Cell Technology in Uveal Melanomas: Current Trends and Perspectives for Improving Uveal Melanoma Metastasis Surveillance and Tumor Profiling. Front Mol Biosci 2020;7:611584. [PMID: 33585560 DOI: 10.3389/fmolb.2020.611584] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
199 Zhong X, Zhang H, Zhu Y, Liang Y, Yuan Z, Li J, Li J, Li X, Jia Y, He T, Zhu J, Sun Y, Jiang W, Zhang H, Wang C, Ke Z. Circulating tumor cells in cancer patients: developments and clinical applications for immunotherapy. Mol Cancer 2020;19:15. [PMID: 31980023 DOI: 10.1186/s12943-020-1141-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
200 Zheng Y, Comaills V, Burr R, Boulay G, Miyamoto DT, Wittner BS, Emmons E, Sil S, Koulopoulos MW, Broderick KT, Tai E, Rengarajan S, Kulkarni AS, Shioda T, Wu CL, Ramaswamy S, Ting DT, Toner M, Rivera MN, Maheswaran S, Haber DA. COX-2 mediates tumor-stromal prolactin signaling to initiate tumorigenesis. Proc Natl Acad Sci U S A 2019;116:5223-32. [PMID: 30819896 DOI: 10.1073/pnas.1819303116] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
201 Taha EA, Ono K, Eguchi T. Roles of Extracellular HSPs as Biomarkers in Immune Surveillance and Immune Evasion. Int J Mol Sci 2019;20:E4588. [PMID: 31533245 DOI: 10.3390/ijms20184588] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 13.7] [Reference Citation Analysis]
202 Yoon Y, Lee J, Yoo KC, Sul O, Lee SJ, Lee SB. Deterministic Capture of Individual Circulating Tumor Cells Using a Flow-Restricted Microfluidic Trap Array. Micromachines (Basel) 2018;9:E106. [PMID: 30424040 DOI: 10.3390/mi9030106] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
203 El Achi H, Khoury JD, Loghavi S. Liquid Biopsy by Next-Generation Sequencing: a Multimodality Test for Management of Cancer. Curr Hematol Malig Rep 2019;14:358-67. [PMID: 31346903 DOI: 10.1007/s11899-019-00532-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
204 Fonseca FLA, da Veiga GL, Alves BDCA, Alves SIPMDN. Liquid biopsy in cancer using the Z-scan technique: a new approach to discover biomarkers in cancer. Future Sci OA 2020;7:FSO638. [PMID: 33437502 DOI: 10.2144/fsoa-2020-0054] [Reference Citation Analysis]
205 Kaur P, Campo D, Porras TB, Ring A, Lu J, Chairez Y, Su Y, Kang I, Lang JE. A Pilot Study for the Feasibility of Exome-Sequencing in Circulating Tumor Cells Versus Single Metastatic Biopsies in Breast Cancer. Int J Mol Sci 2020;21:E4826. [PMID: 32650480 DOI: 10.3390/ijms21144826] [Reference Citation Analysis]
206 Chalopin A, Tellez-Gabriel M, Brown HK, Vallette F, Heymann MF, Gouin F, Heymann D. Isolation of circulating tumor cells in a preclinical model of osteosarcoma: Effect of chemotherapy. J Bone Oncol 2018;12:83-90. [PMID: 30123735 DOI: 10.1016/j.jbo.2018.07.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
207 Hamza B, Ng SR, Prakadan SM, Delgado FF, Chin CR, King EM, Yang LF, Davidson SM, DeGouveia KL, Cermak N, Navia AW, Winter PS, Drake RS, Tammela T, Li CM, Papagiannakopoulos T, Gupta AJ, Shaw Bagnall J, Knudsen SM, Vander Heiden MG, Wasserman SC, Jacks T, Shalek AK, Manalis SR. Optofluidic real-time cell sorter for longitudinal CTC studies in mouse models of cancer. Proc Natl Acad Sci U S A 2019;116:2232-6. [PMID: 30674677 DOI: 10.1073/pnas.1814102116] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 9.0] [Reference Citation Analysis]
208 Gallerani G, Fici P, Fabbri F. Circulating Tumor Cells: Back to the Future. Front Oncol. 2017;6:275. [PMID: 28123996 DOI: 10.3389/fonc.2016.00275] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
209 Harada K, Rogers JE, Iwatsuki M, Yamashita K, Baba H, Ajani JA. Recent advances in treating oesophageal cancer. F1000Res 2020;9:F1000 Faculty Rev-1189. [PMID: 33042518 DOI: 10.12688/f1000research.22926.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
210 Walter V, Fischer C, Deutsch TM, Ersing C, Nees J, Schütz F, Fremd C, Grischke EM, Sinn P, Brucker SY, Schneeweiss A, Hartkopf AD, Wallwiener M. Estrogen, progesterone, and human epidermal growth factor receptor 2 discordance between primary and metastatic breast cancer. Breast Cancer Res Treat 2020;183:137-44. [PMID: 32613540 DOI: 10.1007/s10549-020-05746-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
211 Ghassemi P, Ren X, Foster BM, Kerr BA, Agah M. Post-enrichment circulating tumor cell detection and enumeration via deformability impedance cytometry. Biosens Bioelectron 2020;150:111868. [PMID: 31767345 DOI: 10.1016/j.bios.2019.111868] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
212 Li L, Han B, Wang Y, Shi H, Zhao J, Li G. Gold Nanoparticles-based Bio-Sensing Methods for Tumor-related Biomedical Applications in Bodily Fluids. CNANO 2020;16:425-40. [DOI: 10.2174/1573413715666190206152717] [Reference Citation Analysis]
213 Brychta N, Drosch M, Driemel C, Fischer JC, Neves RP, Esposito I, Knoefel W, Möhlendick B, Hille C, Stresemann A, Krahn T, Kassack MU, Stoecklein NH, von Ahsen O. Isolation of circulating tumor cells from pancreatic cancer by automated filtration. Oncotarget 2017;8:86143-56. [PMID: 29156783 DOI: 10.18632/oncotarget.21026] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
214 Tsai CF, Zhang P, Scholten D, Martin K, Wang YT, Zhao R, Chrisler WB, Patel DB, Dou M, Jia Y, Reduzzi C, Liu X, Moore RJ, Burnum-Johnson KE, Lin MH, Hsu CC, Jacobs JM, Kagan J, Srivastava S, Rodland KD, Steven Wiley H, Qian WJ, Smith RD, Zhu Y, Cristofanilli M, Liu T, Liu H, Shi T. Surfactant-assisted one-pot sample preparation for label-free single-cell proteomics. Commun Biol 2021;4:265. [PMID: 33649493 DOI: 10.1038/s42003-021-01797-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
215 Yamamoto Y, Uemura M, Fujita M, Maejima K, Koh Y, Matsushita M, Nakano K, Hayashi Y, Wang C, Ishizuya Y, Kinouchi T, Hayashi T, Matsuzaki K, Jingushi K, Kato T, Kawashima A, Ujike T, Nagahara A, Fujita K, Imamura R, Nakagawa H, Nonomura N. Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinoma. Cancer Sci 2019;110:617-28. [PMID: 30536551 DOI: 10.1111/cas.13906] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 7.3] [Reference Citation Analysis]
216 Dell'Aquila E, Fulgenzi CAM, Minelli A, Citarella F, Stellato M, Pantano F, Russano M, Cursano MC, Napolitano A, Zeppola T, Vincenzi B, Tonini G, Santini D. Prognostic and predictive factors in pancreatic cancer. Oncotarget 2020;11:924-41. [PMID: 32206189 DOI: 10.18632/oncotarget.27518] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
217 Russo M, Bardelli A. Lesion-Directed Therapies and Monitoring Tumor Evolution Using Liquid Biopsies. Cold Spring Harb Perspect Med 2017;7:a029587. [PMID: 28003276 DOI: 10.1101/cshperspect.a029587] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
218 Kulasinghe A, Perry C, Warkiani ME, Blick T, Davies A, O'Byrne K, Thompson EW, Nelson CC, Vela I, Punyadeera C. Short term ex-vivo expansion of circulating head and neck tumour cells. Oncotarget 2016;7:60101-9. [PMID: 27517751 DOI: 10.18632/oncotarget.11159] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 7.8] [Reference Citation Analysis]
219 Vietsch EE, Graham GT, McCutcheon JN, Javaid A, Giaccone G, Marshall JL, Wellstein A. Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer. Cancer Genet 2017;218-219:39-50. [PMID: 29153095 DOI: 10.1016/j.cancergen.2017.08.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
220 Gwak H, Kim J, Kashefi-Kheyrabadi L, Kwak B, Hyun KA, Jung HI. Progress in Circulating Tumor Cell Research Using Microfluidic Devices. Micromachines (Basel) 2018;9:E353. [PMID: 30424286 DOI: 10.3390/mi9070353] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
221 Dong J, Chen JF, Smalley M, Zhao M, Ke Z, Zhu Y, Tseng HR. Nanostructured Substrates for Detection and Characterization of Circulating Rare Cells: From Materials Research to Clinical Applications. Adv Mater 2020;32:e1903663. [PMID: 31566837 DOI: 10.1002/adma.201903663] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
222 Lopes C, Piairo P, Chícharo A, Abalde-Cela S, Pires LR, Corredeira P, Alves P, Muinelo-Romay L, Costa L, Diéguez L. HER2 Expression in Circulating Tumour Cells Isolated from Metastatic Breast Cancer Patients Using a Size-Based Microfluidic Device. Cancers (Basel) 2021;13:4446. [PMID: 34503260 DOI: 10.3390/cancers13174446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
223 Hofman P, Popper HH. Pathologists and liquid biopsies: to be or not to be? Virchows Arch 2016;469:601-9. [PMID: 27553354 DOI: 10.1007/s00428-016-2004-z] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 6.3] [Reference Citation Analysis]
224 Heikenwalder M, Lorentzen A. The role of polarisation of circulating tumour cells in cancer metastasis. Cell Mol Life Sci 2019;76:3765-81. [PMID: 31218452 DOI: 10.1007/s00018-019-03169-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
225 Fotheringham S, Mozolowski GA, Murray EMA, Kerr DJ. Challenges and solutions in patient treatment strategies for stage II colon cancer. Gastroenterol Rep (Oxf) 2019;7:151-61. [PMID: 31217978 DOI: 10.1093/gastro/goz006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
226 Rossi T, Gallerani G, Martinelli G, Maltoni R, Fabbri F. Circulating Tumor Cells as a Tool to Untangle the Breast Cancer Heterogeneity Issue. Biomedicines 2021;9:1242. [PMID: 34572427 DOI: 10.3390/biomedicines9091242] [Reference Citation Analysis]
227 Bellassai N, D'Agata R, Jungbluth V, Spoto G. Surface Plasmon Resonance for Biomarker Detection: Advances in Non-invasive Cancer Diagnosis. Front Chem 2019;7:570. [PMID: 31448267 DOI: 10.3389/fchem.2019.00570] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 15.0] [Reference Citation Analysis]
228 Turetta M, Ben FD, Brisotto G, Biscontin E, Bulfoni M, Cesselli D, Colombatti A, Scoles G, Gigli G, Del Mercato LL. Emerging Technologies for Cancer Research: Towards Personalized Medicine with Microfluidic Platforms and 3D Tumor Models. Curr Med Chem 2018;25:4616-37. [PMID: 29874987 DOI: 10.2174/0929867325666180605122633] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
229 Fares J, Fares MY, Khachfe HH, Salhab HA, Fares Y. Molecular principles of metastasis: a hallmark of cancer revisited. Signal Transduct Target Ther 2020;5:28. [PMID: 32296047 DOI: 10.1038/s41392-020-0134-x] [Cited by in Crossref: 163] [Cited by in F6Publishing: 154] [Article Influence: 81.5] [Reference Citation Analysis]
230 Dominguez GA, Polo AT, Roop J, Campisi AJ, Somer RA, Perzin AD, Gabrilovich DI, Kumar A. Detecting Prostate Cancer Using Pattern Recognition Neural Networks With Flow Cytometry-Based Immunophenotyping in At-Risk Men. Biomark Insights 2020;15:1177271920913320. [PMID: 32341637 DOI: 10.1177/1177271920913320] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
231 Agerbæk MØ, Bang-Christensen SR, Yang MH, Clausen TM, Pereira MA, Sharma S, Ditlev SB, Nielsen MA, Choudhary S, Gustavsson T, Sorensen PH, Meyer T, Propper D, Shamash J, Theander TG, Aicher A, Daugaard M, Heeschen C, Salanti A. The VAR2CSA malaria protein efficiently retrieves circulating tumor cells in an EpCAM-independent manner. Nat Commun 2018;9:3279. [PMID: 30115931 DOI: 10.1038/s41467-018-05793-2] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 14.0] [Reference Citation Analysis]
232 Barbosa A, Pinto P, Peixoto A, Guerra J, Pinheiro M, Santos C, Pinto C, Escudeiro C, Bartosch C, Santos R, Brandão A, Silva J, Teixeira MR. Next Generation Sequencing of Tumor and Matched Plasma Samples: Identification of Somatic Variants in ctDNA From Ovarian Cancer Patients. Front Oncol 2021;11:754094. [PMID: 34660321 DOI: 10.3389/fonc.2021.754094] [Reference Citation Analysis]
233 Russano M, Napolitano A, Ribelli G, Iuliani M, Simonetti S, Citarella F, Pantano F, Dell'Aquila E, Anesi C, Silvestris N, Argentiero A, Solimando AG, Vincenzi B, Tonini G, Santini D. Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples. J Exp Clin Cancer Res 2020;39:95. [PMID: 32460897 DOI: 10.1186/s13046-020-01601-2] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 20.0] [Reference Citation Analysis]
234 Papadaki MA, Messaritakis I, Fiste O, Souglakos J, Politaki E, Kotsakis A, Georgoulias V, Mavroudis D, Agelaki S. Assessment of the Efficacy and Clinical Utility of Different Circulating Tumor Cell (CTC) Detection Assays in Patients with Chemotherapy-Naïve Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC). Int J Mol Sci 2021;22:E925. [PMID: 33477700 DOI: 10.3390/ijms22020925] [Reference Citation Analysis]
235 Beffagna G, Sammarco A, Bedin C, Romualdi C, Mainenti M, Mollo A, Cavicchioli L, Ferro S, Trez D, De Maria R, Nitti D, Saccani A, Campanella M, Agostini M, Zappulli V. Circulating Cell-Free DNA in Dogs with Mammary Tumors: Short and Long Fragments and Integrity Index. PLoS One 2017;12:e0169454. [PMID: 28081183 DOI: 10.1371/journal.pone.0169454] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
236 Lianidou E. Detection and relevance of epigenetic markers on ctDNA: recent advances and future outlook. Mol Oncol 2021;15:1683-700. [PMID: 33942482 DOI: 10.1002/1878-0261.12978] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
237 De Luca G, Cardinali B, Del Mastro L, Lastraioli S, Carli F, Ferrarini M, Calin GA, Garuti A, Mazzitelli C, Zupo S, Dono M. Optimization of a WGA-Free Molecular Tagging-Based NGS Protocol for CTCs Mutational Profiling. Int J Mol Sci 2020;21:E4364. [PMID: 32575430 DOI: 10.3390/ijms21124364] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
238 Chemi F, Mohan S, Guevara T, Clipson A, Rothwell DG, Dive C. Early Dissemination of Circulating Tumor Cells: Biological and Clinical Insights. Front Oncol 2021;11:672195. [PMID: 34026650 DOI: 10.3389/fonc.2021.672195] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
239 Gorges K, Wiltfang L, Gorges TM, Sartori A, Hildebrandt L, Keller L, Volkmer B, Peine S, Babayan A, Moll I, Schneider SW, Twarock S, Mohr P, Fischer JW, Pantel K. Intra-Patient Heterogeneity of Circulating Tumor Cells and Circulating Tumor DNA in Blood of Melanoma Patients. Cancers (Basel) 2019;11:E1685. [PMID: 31671846 DOI: 10.3390/cancers11111685] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
240 Lim MS, Beyer T, Babayan A, Bergmann M, Brehme M, Buyx A, Czernin J, Egger G, Elenitoba-Johnson KSJ, Gückel B, Jačan A, Haslacher H, Hicks RJ, Kenner L, Langanke M, Mitterhauser M, Pichler BJ, Salih HR, Schibli R, Schulz S, Simecek J, Simon J, Soares MO, Stelzl U, Wadsak W, Zatloukal K, Zeitlinger M, Hacker M. Advancing Biomarker Development Through Convergent Engagement: Summary Report of the 2nd International Danube Symposium on Biomarker Development, Molecular Imaging and Applied Diagnostics; March 14-16, 2018; Vienna, Austria. Mol Imaging Biol 2020;22:47-65. [PMID: 31049831 DOI: 10.1007/s11307-019-01361-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
241 Nakamura Y, Sanai H, Miwa I. Remarkable response of recurrent endometrial adenocarcinoma to daily oral administration of half-dose etoposide. SAGE Open Med Case Rep 2018;6:2050313X18819599. [PMID: 30788108 DOI: 10.1177/2050313X18819599] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
242 Domínguez-Vigil IG, Moreno-Martínez AK, Wang JY, Roehrl MHA, Barrera-Saldaña HA. The dawn of the liquid biopsy in the fight against cancer. Oncotarget 2018;9:2912-22. [PMID: 29416824 DOI: 10.18632/oncotarget.23131] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 9.4] [Reference Citation Analysis]
243 Hofman P. ALK Status Assessment with Liquid Biopsies of Lung Cancer Patients. Cancers (Basel) 2017;9:E106. [PMID: 28805673 DOI: 10.3390/cancers9080106] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
244 Ramón Y Cajal S, Hümmer S, Peg V, Guiu XM, De Torres I, Castellvi J, Martinez-Saez E, Hernandez-Losa J. Integrating clinical, molecular, proteomic and histopathological data within the tissue context: tissunomics. Histopathology 2019;75:4-19. [PMID: 30667539 DOI: 10.1111/his.13828] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
245 Marcatti M, Saada J, Okereke I, Wade CE, Bossmann SH, Motamedi M, Szczesny B. Quantification of Circulating Cell Free Mitochondrial DNA in Extracellular Vesicles with PicoGreen™ in Liquid Biopsies: Fast Assessment of Disease/Trauma Severity. Cells 2021;10:819. [PMID: 33917426 DOI: 10.3390/cells10040819] [Reference Citation Analysis]
246 Thiele JA, Pitule P, Hicks J, Kuhn P. Single-Cell Analysis of Circulating Tumor Cells. Methods Mol Biol 2019;1908:243-64. [PMID: 30649733 DOI: 10.1007/978-1-4939-9004-7_17] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
247 Remon J, García-Campelo R, de Álava E, Vera R, Rodríguez-Peralto JL, Rodríguez-Lescure Á, Bellosillo B, Garrido P, Rojo F, Álvarez-Alegret R. Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology. Clin Transl Oncol 2020;22:823-34. [PMID: 31559582 DOI: 10.1007/s12094-019-02211-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
248 Lowes LE, Bratman SV, Dittamore R, Done S, Kelley SO, Mai S, Morin RD, Wyatt AW, Allan AL. Circulating Tumor Cells (CTC) and Cell-Free DNA (cfDNA) Workshop 2016: Scientific Opportunities and Logistics for Cancer Clinical Trial Incorporation. Int J Mol Sci 2016;17:E1505. [PMID: 27618023 DOI: 10.3390/ijms17091505] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 7.3] [Reference Citation Analysis]
249 Koch C, Joosse SA, Schneegans S, Wilken OJW, Janning M, Loreth D, Müller V, Prieske K, Banys-Paluchowski M, Horst LJ, Loges S, Peine S, Wikman H, Gorges TM, Pantel K. Pre-Analytical and Analytical Variables of Label-Independent Enrichment and Automated Detection of Circulating Tumor Cells in Cancer Patients. Cancers (Basel) 2020;12:E442. [PMID: 32069934 DOI: 10.3390/cancers12020442] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
250 Gobbini E, Swalduz A, Levra MG, Ortiz-Cuaran S, Toffart AC, Pérol M, Moro-Sibilot D, Saintigny P. Implementing ctDNA Analysis in the Clinic: Challenges and Opportunities in Non-Small Cell Lung Cancer. Cancers (Basel) 2020;12:E3112. [PMID: 33114393 DOI: 10.3390/cancers12113112] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
251 Qin D. Next-generation sequencing and its clinical application. Cancer Biol Med 2019;16:4-10. [PMID: 31119042 DOI: 10.20892/j.issn.2095-3941.2018.0055] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
252 Galarza Fortuna GM, Dvir K. Circulating tumor DNA: Where are we now? A mini review of the literature. World J Clin Oncol 2020; 11(9): 723-731 [PMID: 33033694 DOI: 10.5306/wjco.v11.i9.723] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
253 Koh G, Degasperi A, Zou X, Momen S, Nik-Zainal S. Mutational signatures: emerging concepts, caveats and clinical applications. Nat Rev Cancer 2021. [PMID: 34316057 DOI: 10.1038/s41568-021-00377-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
254 Han X, Wang J, Sun Y. Circulating Tumor DNA as Biomarkers for Cancer Detection. Genomics Proteomics Bioinformatics 2017;15:59-72. [PMID: 28392479 DOI: 10.1016/j.gpb.2016.12.004] [Cited by in Crossref: 113] [Cited by in F6Publishing: 101] [Article Influence: 22.6] [Reference Citation Analysis]
255 Miyamoto DT, Ting DT, Toner M, Maheswaran S, Haber DA. Single-Cell Analysis of Circulating Tumor Cells as a Window into Tumor Heterogeneity. Cold Spring Harb Symp Quant Biol 2016;81:269-74. [PMID: 28389596 DOI: 10.1101/sqb.2016.81.031120] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
256 Harryman WL, Hinton JP, Rubenstein CP, Singh P, Nagle RB, Parker SJ, Knudsen BS, Cress AE. The Cohesive Metastasis Phenotype in Human Prostate Cancer. Biochim Biophys Acta 2016;1866:221-31. [PMID: 27678419 DOI: 10.1016/j.bbcan.2016.09.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
257 Ulrich BC, Guibert N. Non-invasive assessment of tumor PD-L1 status with circulating tumor cells. Ann Transl Med 2018;6:S48. [PMID: 30613623 DOI: 10.21037/atm.2018.10.09] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
258 Chopra B, Sureshkumar KK. Emerging role of cell-free DNA in kidney transplantation. World J Exp Med 2021; 11(5): 55-65 [PMID: 34877265 DOI: 10.5493/wjem.v11.i5.55] [Reference Citation Analysis]
259 Mathai RA, Vidya RVS, Reddy BS, Thomas L, Udupa K, Kolesar J, Rao M. Potential Utility of Liquid Biopsy as a Diagnostic and Prognostic Tool for the Assessment of Solid Tumors: Implications in the Precision Oncology. J Clin Med 2019;8:E373. [PMID: 30889786 DOI: 10.3390/jcm8030373] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 15.0] [Reference Citation Analysis]
260 Cristall K, Bidard FC, Pierga JY, Rauh MJ, Popova T, Sebbag C, Lantz O, Stern MH, Mueller CR. A DNA methylation-based liquid biopsy for triple-negative breast cancer. NPJ Precis Oncol 2021;5:53. [PMID: 34135468 DOI: 10.1038/s41698-021-00198-9] [Reference Citation Analysis]
261 Piao XM, Cha EJ, Yun SJ, Kim WJ. Role of Exosomal miRNA in Bladder Cancer: A Promising Liquid Biopsy Biomarker. Int J Mol Sci 2021;22:1713. [PMID: 33567779 DOI: 10.3390/ijms22041713] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
262 Lee AC, Lee Y, Lee D, Kwon S. Divide and conquer: A perspective on biochips for single-cell and rare-molecule analysis by next-generation sequencing. APL Bioeng 2019;3:020901. [PMID: 31431936 DOI: 10.1063/1.5095962] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
263 Phallen J, Leal A, Woodward BD, Forde PM, Naidoo J, Marrone KA, Brahmer JR, Fiksel J, Medina JE, Cristiano S, Palsgrove DN, Gocke CD, Bruhm DC, Keshavarzian P, Adleff V, Weihe E, Anagnostou V, Scharpf RB, Velculescu VE, Husain H. Early Noninvasive Detection of Response to Targeted Therapy in Non-Small Cell Lung Cancer. Cancer Res 2019;79:1204-13. [PMID: 30573519 DOI: 10.1158/0008-5472.CAN-18-1082] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
264 Bunda S, Zuccato JA, Voisin MR, Wang JZ, Nassiri F, Patil V, Mansouri S, Zadeh G. Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors. Int J Mol Sci 2021;22:4548. [PMID: 33925295 DOI: 10.3390/ijms22094548] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
265 Jin E, Burnier JV. Liquid Biopsy in Uveal Melanoma: Are We There Yet? Ocul Oncol Pathol 2021;7:1-16. [PMID: 33796511 DOI: 10.1159/000508613] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
266 Cote GJ, Evers C, Hu MI, Grubbs EG, Williams MD, Hai T, Duose DY, Houston MR, Bui JH, Mehrotra M, Waguespack SG, Busaidy NL, Cabanillas ME, Habra MA, Luthra R, Sherman SI. Prognostic Significance of Circulating RET M918T Mutated Tumor DNA in Patients With Advanced Medullary Thyroid Carcinoma. J Clin Endocrinol Metab 2017;102:3591-9. [PMID: 28911154 DOI: 10.1210/jc.2017-01039] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
267 Watanabe M, Kenmotsu H, Ko R, Wakuda K, Ono A, Imai H, Taira T, Naito T, Murakami H, Abe M, Endo M, Nakajima T, Koh Y, Takahashi T. Isolation and molecular analysis of circulating tumor cells from lung cancer patients using a microfluidic chip type cell sorter. Cancer Sci 2018;109:2539-48. [PMID: 29900633 DOI: 10.1111/cas.13692] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
268 Paoletti C, Cani AK, Larios JM, Hovelson DH, Aung K, Darga EP, Cannell EM, Baratta PJ, Liu CJ, Chu D, Yazdani M, Blevins AR, Sero V, Tokudome N, Thomas DG, Gersch C, Schott AF, Wu YM, Lonigro R, Robinson DR, Chinnaiyan AM, Bischoff FZ, Johnson MD, Park BH, Hayes DF, Rae JM, Tomlins SA. Comprehensive Mutation and Copy Number Profiling in Archived Circulating Breast Cancer Tumor Cells Documents Heterogeneous Resistance Mechanisms. Cancer Res 2018;78:1110-22. [PMID: 29233927 DOI: 10.1158/0008-5472.CAN-17-2686] [Cited by in Crossref: 49] [Cited by in F6Publishing: 32] [Article Influence: 9.8] [Reference Citation Analysis]
269 Marimpietri D, Airoldi I, Faini AC, Malavasi F, Morandi F. The Role of Extracellular Vesicles in the Progression of Human Neuroblastoma. Int J Mol Sci 2021;22:3964. [PMID: 33921337 DOI: 10.3390/ijms22083964] [Reference Citation Analysis]
270 Guo J, Guo L, Sun L, Wu Z, Ye J, Liu J, Zuo Q. Capture-based ultra-deep sequencing in plasma ctDNA reveals the resistance mechanism of ALK inhibitors in a patient with advanced ALK-positive NSCLC. Cancer Biol Ther 2018;19:359-63. [PMID: 29400604 DOI: 10.1080/15384047.2018.1433496] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
271 Lozar T, Gersak K, Cemazar M, Kuhar CG, Jesenko T. The biology and clinical potential of circulating tumor cells. Radiol Oncol 2019;53:131-47. [PMID: 31104002 DOI: 10.2478/raon-2019-0024] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 7.0] [Reference Citation Analysis]
272 Agnoletto C, Minotti L, Brulle-Soumare L, Pasquali L, Galasso M, Corrà F, Baldassari F, Judde JG, Cairo S, Volinia S. Heterogeneous expression of EPCAM in human circulating tumour cells from patient-derived xenografts. Biomark Res 2018;6:31. [PMID: 30450210 DOI: 10.1186/s40364-018-0145-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
273 Yu J, Wang Z, Zhang H, Wang Y, Li DQ. Survivin-positive circulating tumor cells as a marker for metastasis of hepatocellular carcinoma. World J Gastroenterol 2021; 27(43): 7546-7562 [PMID: 34887648 DOI: 10.3748/wjg.v27.i43.7546] [Reference Citation Analysis]
274 Tang Y, Qiao G, Xu E, Xuan Y, Liao M, Yin G. Biomarkers for early diagnosis, prognosis, prediction, and recurrence monitoring of non-small cell lung cancer. Onco Targets Ther. 2017;10:4527-4534. [PMID: 28979144 DOI: 10.2147/ott.s142149] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
275 Mazzarella L. Are we ready for routine precision medicine? Highlights from the Milan Summit on Precision Medicine, Milan, Italy, 8-9 February 2018. Ecancermedicalscience 2018;12:817. [PMID: 29662530 DOI: 10.3332/ecancer.2018.817] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
276 Tang Y, Liu X, Ou Z, He Z, Zhu Q, Wang Y, Yang M, Ye J, Han-Zhang H, Qiao G. Maximum allele frequency observed in plasma: A potential indicator of liquid biopsy sensitivity. Oncol Lett 2019;18:2118-24. [PMID: 31423285 DOI: 10.3892/ol.2019.10490] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
277 Castro-Giner F, Gkountela S, Donato C, Alborelli I, Quagliata L, Ng CKY, Piscuoglio S, Aceto N. Cancer Diagnosis Using a Liquid Biopsy: Challenges and Expectations. Diagnostics (Basel) 2018;8:E31. [PMID: 29747380 DOI: 10.3390/diagnostics8020031] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 12.5] [Reference Citation Analysis]
278 George SL, Izquierdo E, Campbell J, Koutroumanidou E, Proszek P, Jamal S, Hughes D, Yuan L, Marshall LV, Carceller F, Chisholm JC, Vaidya S, Mandeville H, Angelini P, Wasti A, Bexelius T, Thway K, Gatz SA, Clarke M, Al-Lazikani B, Barone G, Anderson J, Tweddle DA, Gonzalez D, Walker BA, Barton J, Depani S, Eze J, Ahmed SW, Moreno L, Pearson A, Shipley J, Jones C, Hargrave D, Jacques TS, Hubank M, Chesler L. A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations. Eur J Cancer 2019;121:224-35. [PMID: 31543384 DOI: 10.1016/j.ejca.2019.07.027] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
279 Perales Palacios I, García Campos F, Michaus Oquiñena L, Blanco Guzmán S, Lantero Benedito M. [Isolation of Plesiomonas shigelloides in a case of gastroenteritis]. Rev Clin Esp 1983;171:115-7. [PMID: 6658089 [PMID: 6658089 DOI: 10.1038/s41571-018-0002-6] [Cited by in Crossref: 125] [Cited by in F6Publishing: 119] [Article Influence: 3.3] [Reference Citation Analysis]
280 Gallo M, De Luca A, Maiello MR, D'Alessio A, Esposito C, Chicchinelli N, Forgione L, Piccirillo MC, Rocco G, Morabito A, Botti G, Normanno N. Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer. Transl Lung Cancer Res 2017;6:486-98. [PMID: 28904891 DOI: 10.21037/tlcr.2017.05.07] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
281 Lin PP. Aneuploid CTC and CEC. Diagnostics (Basel) 2018;8:E26. [PMID: 29670052 DOI: 10.3390/diagnostics8020026] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
282 Stergiopoulou D, Markou A, Tzanikou E, Ladas I, Makrigiorgos GM, Georgoulias V, Lianidou E. ESR1 NAPA Assay: Development and Analytical Validation of a Highly Sensitive and Specific Blood-Based Assay for the Detection of ESR1 Mutations in Liquid Biopsies. Cancers (Basel) 2021;13:556. [PMID: 33535614 DOI: 10.3390/cancers13030556] [Reference Citation Analysis]
283 Broncy L, Njima BB, Méjean A, Béroud C, Romdhane KB, Ilie M, Hofman V, Muret J, Hofman P, Bouhamed HC, Paterlini-Bréchot AP. Single-cell genetic analysis validates cytopathological identification of circulating cancer cells in patients with clear cell renal cell carcinoma. Oncotarget 2018;9:20058-74. [PMID: 29732003 DOI: 10.18632/oncotarget.25102] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
284 Rossi T, Palleschi M, Angeli D, Tebaldi M, Martinelli G, Vannini I, Puccetti M, Limarzi F, Maltoni R, Gallerani G, Fabbri F. Case Report: Analysis of Circulating Tumor Cells in a Triple Negative Spindle-Cell Metaplastic Breast Cancer Patient. Front Med (Lausanne) 2021;8:689895. [PMID: 34249978 DOI: 10.3389/fmed.2021.689895] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
285 Park G, Park JK, Shin SH, Jeon HJ, Kim NKD, Kim YJ, Shin HT, Lee E, Lee KH, Son DS, Park WY, Park D. Characterization of background noise in capture-based targeted sequencing data. Genome Biol 2017;18:136. [PMID: 28732520 DOI: 10.1186/s13059-017-1275-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 6.8] [Reference Citation Analysis]
286 Osumi H, Shinozaki E, Yamaguchi K. Circulating Tumor DNA as a Novel Biomarker Optimizing Chemotherapy for Colorectal Cancer. Cancers (Basel) 2020;12:E1566. [PMID: 32545750 DOI: 10.3390/cancers12061566] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
287 Rantalainen M. Application of single-cell sequencing in human cancer. Brief Funct Genomics 2018;17:273-82. [PMID: 29106464 DOI: 10.1093/bfgp/elx036] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
288 Nikolouzakis TK, Vassilopoulou L, Fragkiadaki P, Mariolis Sapsakos T, Papadakis GZ, Spandidos DA, Tsatsakis AM, Tsiaoussis J. Improving diagnosis, prognosis and prediction by using biomarkers in CRC patients (Review). Oncol Rep 2018;39:2455-72. [PMID: 29565457 DOI: 10.3892/or.2018.6330] [Cited by in Crossref: 18] [Cited by in F6Publishing: 31] [Article Influence: 4.5] [Reference Citation Analysis]
289 Mellert HS, Alexander KE, Jackson LP, Pestano GA. A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction. J Vis Exp 2018. [PMID: 29683453 DOI: 10.3791/57079] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
290 Earl J. Towards a more sensitive detection of somatic mutations in cell-free DNA. EBioMedicine 2019;41:23. [PMID: 30894282 DOI: 10.1016/j.ebiom.2019.02.053] [Reference Citation Analysis]
291 Gaglani S, Gonzalez-Kozlova E, Lundon DJ, Tewari AK, Dogra N, Kyprianou N. Exosomes as A Next-Generation Diagnostic and Therapeutic Tool in Prostate Cancer. Int J Mol Sci 2021;22:10131. [PMID: 34576294 DOI: 10.3390/ijms221810131] [Reference Citation Analysis]
292 White MD, Klein RH, Shaw B, Kim A, Subramanian M, Mora JL, Giobbie-Hurder A, Nagabhushan D, Jain A, Singh M, Kuter BM, Nayyar N, Bertalan MS, Stocking JH, Markson SC, Lastrapes M, Alvarez-Breckenridge C, Cahill DP, Gydush G, Rhoades J, Rotem D, Adalsteinsson VA, Mahar M, Kaplan A, Oh K, Sullivan RJ, Gerstner E, Carter SL, Brastianos PK. Detection of Leptomeningeal Disease Using Cell-Free DNA From Cerebrospinal Fluid. JAMA Netw Open 2021;4:e2120040. [PMID: 34369989 DOI: 10.1001/jamanetworkopen.2021.20040] [Reference Citation Analysis]
293 Kulasinghe A, Tran TH, Blick T, O'Byrne K, Thompson EW, Warkiani ME, Nelson C, Kenny L, Punyadeera C. Enrichment of circulating head and neck tumour cells using spiral microfluidic technology. Sci Rep 2017;7:42517. [PMID: 28198401 DOI: 10.1038/srep42517] [Cited by in Crossref: 48] [Cited by in F6Publishing: 48] [Article Influence: 9.6] [Reference Citation Analysis]
294 Kulasinghe A, Perry C, Kenny L, Warkiani ME, Nelson C, Punyadeera C. PD-L1 expressing circulating tumour cells in head and neck cancers. BMC Cancer 2017;17:333. [PMID: 28511705 DOI: 10.1186/s12885-017-3316-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 6.8] [Reference Citation Analysis]
295 Zon G. Recent advances in aptamer applications for analytical biochemistry. Anal Biochem 2020;:113894. [PMID: 32763306 DOI: 10.1016/j.ab.2020.113894] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
296 Kim H, Heo CM, Oh J, Chung HH, Lee EM, Park J, Lee SH, Lee KH, Lee KT, Lee JK, Cho YK, Park JK. Clinical significance of circulating tumor cells after chemotherapy in unresectable pancreatic ductal adenocarcinoma. Transl Oncol 2021;16:101321. [PMID: 34954457 DOI: 10.1016/j.tranon.2021.101321] [Reference Citation Analysis]
297 Kong L, Birkeland AC. Liquid Biopsies in Head and Neck Cancer: Current State and Future Challenges. Cancers (Basel) 2021;13:1874. [PMID: 33919778 DOI: 10.3390/cancers13081874] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
298 Sierra J, Marrugo-Ramirez J, Rodríguez-Trujillo R, Mir M, Samitier J. Sensor-Integrated Microfluidic Approaches for Liquid Biopsies Applications in Early Detection of Cancer. Sensors (Basel) 2020;20:E1317. [PMID: 32121271 DOI: 10.3390/s20051317] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
299 Cabel L, Decraene C, Bieche I, Pierga JY, Bennamoun M, Fuks D, Ferraz JM, Lefevre M, Baulande S, Bernard V, Vacher S, Mariani P, Proudhon C, Bidard FC, Louvet C. Limited Sensitivity of Circulating Tumor DNA Detection by Droplet Digital PCR in Non-Metastatic Operable Gastric Cancer Patients. Cancers (Basel) 2019;11:E396. [PMID: 30901876 DOI: 10.3390/cancers11030396] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
300 Zhang X, Ju S, Wang X, Cong H. Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer. Clin Exp Med 2019;19:271-9. [PMID: 31190187 DOI: 10.1007/s10238-019-00563-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
301 Zhao P, Zhou W, Liu C, Zhang H, Cheng Z, Wu W, Liu K, Hu H, Zhong C, Zhang Y, Zhou D, Liu F, Dai Y, Wang J, Zou C. Establishment and Characterization of a CTC Cell Line from Peripheral Blood of Breast Cancer Patient. J Cancer 2019;10:6095-104. [PMID: 31762819 DOI: 10.7150/jca.33157] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
302 González-Conde M, Yañez-Gómez C, López-López R, Costa C. Liquid Biopsy: A New Tool for Overcoming CDKi Resistance Mechanisms in Luminal Metastatic Breast Cancer. J Pers Med 2021;11:407. [PMID: 34068388 DOI: 10.3390/jpm11050407] [Reference Citation Analysis]
303 Hutchinson MR, Stoddart PR, Mahadevan-Jansen A. Challenges and opportunities in neurophotonics discussed at the International Conference on Biophotonics 2017. Neurophotonics 2018;5:040402. [PMID: 30450362 DOI: 10.1117/1.NPh.5.4.040402] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
304 Goh JY, Feng M, Wang W, Oguz G, Yatim SMJM, Lee PL, Bao Y, Lim TH, Wang P, Tam WL, Kodahl AR, Lyng MB, Sarma S, Lin SY, Lezhava A, Yap YS, Lim AST, Hoon DSB, Ditzel HJ, Lee SC, Tan EY, Yu Q. Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence. Nat Med 2017;23:1319-30. [PMID: 28967919 DOI: 10.1038/nm.4405] [Cited by in Crossref: 56] [Cited by in F6Publishing: 58] [Article Influence: 11.2] [Reference Citation Analysis]
305 Brisotto G, Biscontin E, Rossi E, Bulfoni M, Piruska A, Spazzapan S, Poggiana C, Vidotto R, Steffan A, Colombatti A, Huck WTS, Cesselli D, Zamarchi R, Turetta M, Del Ben F. Dysmetabolic Circulating Tumor Cells Are Prognostic in Metastatic Breast Cancer. Cancers (Basel) 2020;12:E1005. [PMID: 32325824 DOI: 10.3390/cancers12041005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
306 Li L, Zhu Z, Zhao Y, Zhang Q, Wu X, Miao B, Cao J, Fei S. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics. Sci Rep. 2019;9:7827. [PMID: 31127138 DOI: 10.1038/s41598-019-43924-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 30] [Article Influence: 7.7] [Reference Citation Analysis]
307 Guo Z, Xie Z, Shi H, Du W, Peng L, Han W, Duan F, Zhang X, Chen M, Duan J, Lin J, Chen X, Lizaso AA, Han-Zhang H, He J, Yin W. Malignant pleural effusion supernatant is an alternative liquid biopsy specimen for comprehensive mutational profiling. Thorac Cancer 2019;10:823-31. [PMID: 30779318 DOI: 10.1111/1759-7714.13006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
308 Todenhöfer T, Struss WJ, Seiler R, Wyatt AW, Black PC. Liquid Biopsy-Analysis of Circulating Tumor DNA (ctDNA) in Bladder Cancer. Bladder Cancer 2018;4:19-29. [PMID: 29430504 DOI: 10.3233/BLC-170140] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
309 Broncy L, Paterlini-Bréchot P. Circulating Tumor Cells for the Management of Renal Cell Carcinoma. Diagnostics (Basel) 2018;8:E63. [PMID: 30177639 DOI: 10.3390/diagnostics8030063] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
310 Flores BCT, Correia MP, Rodríguez JG, Henrique R, Jerónimo C. Bridging the Gaps between Circulating Tumor Cells and DNA Methylation in Prostate Cancer. Cancers (Basel) 2021;13:4209. [PMID: 34439363 DOI: 10.3390/cancers13164209] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
311 von Felden J, Schulze K, Krech T, Ewald F, Nashan B, Pantel K, Lohse AW, Riethdorf S, Wege H. Circulating tumor cells as liquid biomarker for high HCC recurrence risk after curative liver resection. Oncotarget. 2017;8:89978-89987. [PMID: 29163804 DOI: 10.18632/oncotarget.21208] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
312 Li X, Li C, Zhang L, Wu M, Cao K, Jiang F, Chen D, Li N, Li W. The significance of exosomes in the development and treatment of hepatocellular carcinoma. Mol Cancer 2020;19:1. [PMID: 31901224 DOI: 10.1186/s12943-019-1085-0] [Cited by in Crossref: 70] [Cited by in F6Publishing: 44] [Article Influence: 35.0] [Reference Citation Analysis]
313 Johann DJ Jr, Steliga M, Shin IJ, Yoon D, Arnaoutakis K, Hutchins L, Liu M, Liem J, Walker K, Pereira A, Yang M, Jeffus SK, Peterson E, Xu J. Liquid biopsy and its role in an advanced clinical trial for lung cancer. Exp Biol Med (Maywood) 2018;243:262-71. [PMID: 29405770 DOI: 10.1177/1535370217750087] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
314 Pallante P, Malapelle U, Nacchio M, Sgariglia R, Galati D, Capitelli L, Zanotta S, Galgani M, Piemonte E, Sanduzzi Zamparelli A, Rea G, Bocchino M. Liquid Biopsy Is a Promising Tool for Genetic Testing in Idiopathic Pulmonary Fibrosis. Diagnostics (Basel) 2021;11:1202. [PMID: 34359285 DOI: 10.3390/diagnostics11071202] [Reference Citation Analysis]
315 Yoon Y, Lee J, Ra M, Gwon H, Lee S, Kim MY, Yoo KC, Sul O, Kim CG, Kim WY, Park JG, Lee SJ, Lee YY, Choi HS, Lee SB. Continuous Separation of Circulating Tumor Cells from Whole Blood Using a Slanted Weir Microfluidic Device. Cancers (Basel) 2019;11:E200. [PMID: 30744156 DOI: 10.3390/cancers11020200] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
316 Ko JMY, Ng HY, Lam KO, Chiu KWH, Kwong DLW, Lo AWI, Wong JC, Lin RCW, Fong HCH, Li JYK, Dai W, Law S, Lung ML. Liquid Biopsy Serial Monitoring of Treatment Responses and Relapse in Advanced Esophageal Squamous Cell Carcinoma. Cancers (Basel) 2020;12:E1352. [PMID: 32466419 DOI: 10.3390/cancers12061352] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
317 Avram L, Stefancu A, Crisan D, Leopold N, Donca V, Buzdugan E, Craciun R, Andras D, Coman I. Recent advances in surface-enhanced Raman spectroscopy based liquid biopsy for colorectal cancer (Review). Exp Ther Med 2020;20:213. [PMID: 33149777 DOI: 10.3892/etm.2020.9342] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
318 Redig AJ. Raising the bar: the future of EGFR inhibition in non-small lung cancer. Transl Lung Cancer Res 2017;6:S58-61. [PMID: 29299413 DOI: 10.21037/tlcr.2017.10.09] [Reference Citation Analysis]
319 Frisone D, Friedlaender A, Addeo A. The Role and Impact of Minimal Residual Disease in NSCLC. Curr Oncol Rep 2021;23:136. [PMID: 34735646 DOI: 10.1007/s11912-021-01131-w] [Reference Citation Analysis]
320 Thiele JA, Bethel K, Králíčková M, Kuhn P. Circulating Tumor Cells: Fluid Surrogates of Solid Tumors. Annu Rev Pathol 2017;12:419-47. [PMID: 28135562 DOI: 10.1146/annurev-pathol-052016-100256] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 10.4] [Reference Citation Analysis]
321 Li W, Zhang X, Lu X, You L, Song Y, Luo Z, Zhang J, Nie J, Zheng W, Xu D, Wang Y, Dong Y, Yu S, Hong J, Shi J, Hao H, Luo F, Hua L, Wang P, Qian X, Yuan F, Wei L, Cui M, Zhang T, Liao Q, Dai M, Liu Z, Chen G, Meckel K, Adhikari S, Jia G, Bissonnette MB, Zhao Y, Zhang W, He C, Liu J. 5-Hydroxymethylcytosine signatures in circulating cell-free DNA as diagnostic biomarkers for human cancers. Cell Res. 2017;27:1243-1257. [PMID: 28925386 DOI: 10.1038/cr.2017.121] [Cited by in Crossref: 123] [Cited by in F6Publishing: 110] [Article Influence: 24.6] [Reference Citation Analysis]
322 Olson R, Mathews L, Liu M, Schellenberg D, Mou B, Berrang T, Harrow S, Correa RJM, Bhat V, Pai H, Mohamed I, Miller S, Schneiders F, Laba J, Wilke D, Senthi S, Louie AV, Swaminath A, Chalmers A, Gaede S, Warner A, de Gruijl TD, Allan A, Palma DA. Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial. BMC Cancer 2020;20:380. [PMID: 32370765 DOI: 10.1186/s12885-020-06876-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
323 Song Q, Zhang Y, Liu H, Du Y. Potential of Using Cell-Free DNA and miRNA in Breast Milk to Screen Early Breast Cancer. Biomed Res Int 2020;2020:8126176. [PMID: 32714986 DOI: 10.1155/2020/8126176] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
324 Koch C, Kuske A, Joosse SA, Yigit G, Sflomos G, Thaler S, Smit DJ, Werner S, Borgmann K, Gärtner S, Mossahebi Mohammadi P, Battista L, Cayrefourcq L, Altmüller J, Salinas-Riester G, Raithatha K, Zibat A, Goy Y, Ott L, Bartkowiak K, Tan TZ, Zhou Q, Speicher MR, Müller V, Gorges TM, Jücker M, Thiery JP, Brisken C, Riethdorf S, Alix-Panabières C, Pantel K. Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity. EMBO Mol Med 2020;12:e11908. [PMID: 32667137 DOI: 10.15252/emmm.201911908] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 12.0] [Reference Citation Analysis]
325 Tribukait B. Early prediction of pathologic response to neoadjuvant treatment of breast cancer: use of a cell-loss metric based on serum thymidine kinase 1 and tumour volume. BMC Cancer 2020;20:440. [PMID: 32423477 DOI: 10.1186/s12885-020-06925-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
326 Labgaa I, von Felden J, Craig AJ, Martins-Filho SN, Villacorta-Martin C, Demartines N, Dormond O, D'Avola D, Villanueva A. Experimental Models of Liquid Biopsy in Hepatocellular Carcinoma Reveal Clone-Dependent Release of Circulating Tumor DNA. Hepatol Commun 2021;5:1095-105. [PMID: 34141992 DOI: 10.1002/hep4.1692] [Reference Citation Analysis]
327 Banys-Paluchowski M, Krawczyk N, Fehm T. Liquid Biopsy in Breast Cancer. Geburtshilfe Frauenheilkd. 2020;80:1093-1104. [PMID: 33173237 DOI: 10.1055/a-1124-7225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
328 Zhou L, Dicker DT, Matthew E, El-Deiry WS, Alpaugh RK. Circulating tumor cells: silent predictors of metastasis. F1000Res 2017;6:F1000 Faculty Rev-1445. [PMID: 28868131 DOI: 10.12688/f1000research.11313.1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
329 García-Silva S, Gallardo M, Peinado H. DNA-Loaded Extracellular Vesicles in Liquid Biopsy: Tiny Players With Big Potential? Front Cell Dev Biol 2020;8:622579. [PMID: 33575258 DOI: 10.3389/fcell.2020.622579] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
330 Lim SY, Lee JH, Welsh SJ, Ahn SB, Breen E, Khan A, Carlino MS, Menzies AM, Kefford RF, Scolyer RA, Long GV, Rizos H. Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients. Biomark Res 2017;5:32. [PMID: 29152306 DOI: 10.1186/s40364-017-0112-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
331 Nicolazzo C, Busetto GM, Del Giudice F, Sperduti I, Giannarelli D, Gradilone A, Gazzaniga P, de Berardinis E, Raimondi C. The long-term prognostic value of survivin expressing circulating tumor cells in patients with high-risk non-muscle invasive bladder cancer (NMIBC). J Cancer Res Clin Oncol 2017;143:1971-6. [PMID: 28555356 DOI: 10.1007/s00432-017-2449-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.6] [Reference Citation Analysis]
332 McGuire AL, Hughesman CB, McConechy MK, Melosky B, Lam S, Myers R, Yee J, Tang E, Yip S. Optimizing molecular residual disease detection using liquid biopsy postoperatively in early stage lung cancer. Lung Cancer Manag 2020;9:LMT24. [PMID: 32346401 DOI: 10.2217/lmt-2019-0017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
333 Kulasinghe A, Schmidt H, Perry C, Whitfield B, Kenny L, Nelson C, Warkiani ME, Punyadeera C. A Collective Route to Head and Neck Cancer Metastasis. Sci Rep 2018;8:746. [PMID: 29335441 DOI: 10.1038/s41598-017-19117-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 10.0] [Reference Citation Analysis]
334 Zainfeld D, Goldkorn A. Liquid Biopsy in Prostate Cancer: Circulating Tumor Cells and Beyond. Cancer Treat Res 2018;175:87-104. [PMID: 30168118 DOI: 10.1007/978-3-319-93339-9_4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
335 Hita-Millan J, Carracedo A, Fernandez-Rozadilla C. Liquid Biopsy Biomarkers for Immunotherapy in Non-Small Cell Lung Carcinoma: Lessons Learned and the Road Ahead. J Pers Med 2021;11:971. [PMID: 34683113 DOI: 10.3390/jpm11100971] [Reference Citation Analysis]
336 Fina E, Necchi A, Bottelli S, Reduzzi C, Pizzamiglio S, Iacona C, Daidone MG, Verderio P, Cappelletti V. Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods. Dis Markers 2017;2017:3414910. [PMID: 28321147 DOI: 10.1155/2017/3414910] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
337 Lim M, Kim CJ, Sunkara V, Kim MH, Cho YK. Liquid Biopsy in Lung Cancer: Clinical Applications of Circulating Biomarkers (CTCs and ctDNA). Micromachines (Basel) 2018;9:E100. [PMID: 30424034 DOI: 10.3390/mi9030100] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 9.3] [Reference Citation Analysis]
338 Palma DA, Olson R, Harrow S, Correa RJM, Schneiders F, Haasbeek CJA, Rodrigues GB, Lock M, Yaremko BP, Bauman GS, Ahmad B, Schellenberg D, Liu M, Gaede S, Laba J, Mulroy L, Senthi S, Louie AV, Swaminath A, Chalmers A, Warner A, Slotman BJ, de Gruijl TD, Allan A, Senan S. Stereotactic ablative radiotherapy for the comprehensive treatment of 4-10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial. BMC Cancer 2019;19:816. [PMID: 31426760 DOI: 10.1186/s12885-019-5977-6] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 18.0] [Reference Citation Analysis]
339 Thibault B, Ramos-Delgado F, Pons-Tostivint E, Therville N, Cintas C, Arcucci S, Cassant-Sourdy S, Reyes-Castellanos G, Tosolini M, Villard AV, Cayron C, Baer R, Bertrand-Michel J, Pagan D, Ferreira Da Mota D, Yan H, Falcomatà C, Muscari F, Bournet B, Delord JP, Aksoy E, Carrier A, Cordelier P, Saur D, Basset C, Guillermet-Guibert J. Pancreatic cancer intrinsic PI3Kα activity accelerates metastasis and rewires macrophage component. EMBO Mol Med 2021;13:e13502. [PMID: 34033220 DOI: 10.15252/emmm.202013502] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
340 Cattin S, Fellay B, Calderoni A, Christinat A, Negretti L, Biggiogero M, Badellino A, Schneider AL, Tsoutsou P, Pellanda AF, Rüegg C. Circulating immune cell populations related to primary breast cancer, surgical removal, and radiotherapy revealed by flow cytometry analysis. Breast Cancer Res 2021;23:64. [PMID: 34090509 DOI: 10.1186/s13058-021-01441-8] [Reference Citation Analysis]
341 Tieng FYF, Abu N, Lee LH, Ab Mutalib NS. Microsatellite Instability in Colorectal Cancer Liquid Biopsy-Current Updates on Its Potential in Non-Invasive Detection, Prognosis and as a Predictive Marker. Diagnostics (Basel) 2021;11:544. [PMID: 33803882 DOI: 10.3390/diagnostics11030544] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
342 Xia S, Ye J, Chen Y, Lizaso A, Huang L, Shi L, Su J, Han-Zhang H, Chuai S, Li L, Chen Y. Parallel serial assessment of somatic mutation and methylation profile from circulating tumor DNA predicts treatment response and impending disease progression in osimertinib-treated lung adenocarcinoma patients. Transl Lung Cancer Res 2019;8:1016-28. [PMID: 32010579 DOI: 10.21037/tlcr.2019.12.09] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
343 Green ED, Rubin EM, Olson MV. The future of DNA sequencing. Nature 2017;550:179-81. [PMID: 29022931 DOI: 10.1038/550179a] [Cited by in Crossref: 38] [Cited by in F6Publishing: 24] [Article Influence: 9.5] [Reference Citation Analysis]
344 Hugen CM, Zainfeld DE, Goldkorn A. Circulating Tumor Cells in Genitourinary Malignancies: An Evolving Path to Precision Medicine. Front Oncol 2017;7:6. [PMID: 28191452 DOI: 10.3389/fonc.2017.00006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
345 Hutson N, Zhan F, Graham J, Murakami M, Zhang H, Ganaparti S, Hu Q, Yan L, Ma C, Liu S, Xie J, Wei L. An adaptive method of defining negative mutation status for multi-sample comparison using next-generation sequencing. BMC Med Genomics 2021;14:32. [PMID: 34856988 DOI: 10.1186/s12920-021-00880-8] [Reference Citation Analysis]
346 Kidess-Sigal E, Liu HE, Triboulet MM, Che J, Ramani VC, Visser BC, Poultsides GA, Longacre TA, Marziali A, Vysotskaia V, Wiggin M, Heirich K, Hanft V, Keilholz U, Tinhofer I, Norton JA, Lee M, Sollier-Christen E, Jeffrey SS. Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer. Oncotarget 2016;7:85349-64. [PMID: 27863403 DOI: 10.18632/oncotarget.13350] [Cited by in Crossref: 54] [Cited by in F6Publishing: 52] [Article Influence: 13.5] [Reference Citation Analysis]
347 Hille C, Gorges TM, Riethdorf S, Mazel M, Steuber T, Amsberg GV, König F, Peine S, Alix-Panabières C, Pantel K. Detection of Androgen Receptor Variant 7 (ARV7) mRNA Levels in EpCAM-Enriched CTC Fractions for Monitoring Response to Androgen Targeting Therapies in Prostate Cancer. Cells 2019;8:E1067. [PMID: 31514447 DOI: 10.3390/cells8091067] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
348 Ye Q, Ling S, Zheng S, Xu X. Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA. Mol Cancer. 2019;18:114. [PMID: 31269959 DOI: 10.1186/s12943-019-1043-x] [Cited by in Crossref: 66] [Cited by in F6Publishing: 72] [Article Influence: 22.0] [Reference Citation Analysis]
349 Rodrigo A, Ojeda JL, Vega S, Sanchez-Gracia O, Lanas A, Isla D, Velazquez-Campoy A, Abian O. Thermal Liquid Biopsy (TLB): A Predictive Score Derived from Serum Thermograms as a Clinical Tool for Screening Lung Cancer Patients. Cancers (Basel) 2019;11:E1012. [PMID: 31331013 DOI: 10.3390/cancers11071012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
350 De Luca A, Gallo M, Esposito C, Morabito A, Normanno N. Promising Role of Circulating Tumor Cells in the Management of SCLC. Cancers (Basel) 2021;13:2029. [PMID: 33922300 DOI: 10.3390/cancers13092029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
351 Sollier-Christen E, Renier C, Kaplan T, Kfir E, Crouse SC. VTX-1 Liquid Biopsy System for Fully-Automated and Label-Free Isolation of Circulating Tumor Cells with Automated Enumeration by BioView Platform. Cytometry A 2018;93:1240-5. [PMID: 30211979 DOI: 10.1002/cyto.a.23592] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
352 Salk JJ, Loubet-Senear K, Maritschnegg E, Valentine CC, Williams LN, Higgins JE, Horvat R, Vanderstichele A, Nachmanson D, Baker KT, Emond MJ, Loter E, Tretiakova M, Soussi T, Loeb LA, Zeillinger R, Speiser P, Risques RA. Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan. Cell Rep 2019;28:132-144.e3. [PMID: 31269435 DOI: 10.1016/j.celrep.2019.05.109] [Cited by in Crossref: 40] [Cited by in F6Publishing: 31] [Article Influence: 20.0] [Reference Citation Analysis]
353 Liu C, Sun B, Xu B, Meng X, Li L, Cong Y, Liu J, Wang Q, Xuan L, Song Q, Wu S. A panel containing PD-1, IL-2Rα, IL-10, and CA15-3 as a biomarker to discriminate breast cancer from benign breast disease. Cancer Manag Res 2018;10:1749-61. [PMID: 29983594 DOI: 10.2147/CMAR.S160452] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
354 Lim H, Back SM, Hwang MH, Lee DH, Choi H, Nam J. Sheathless High-Throughput Circulating Tumor Cell Separation Using Viscoelastic non-Newtonian Fluid. Micromachines (Basel) 2019;10:E462. [PMID: 31295917 DOI: 10.3390/mi10070462] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
355 He W, Hou M, Zhang H, Zeng C, He S, Chen X, Xu M, Sun C, Jiang W, Wang H, Shen H, Zhang Y, Liu J, Sun S, Jiang N, Cui Y, Sun Y, Chen Y, Cao J, Wang C, Li M, Zhang Y, Wang L, Wang J, Lin M, Ke Z. Clinical significance of circulating tumor cells in predicting disease progression and chemotherapy resistance in patients with gestational choriocarcinoma. Int J Cancer 2019;144:1421-31. [PMID: 30070688 DOI: 10.1002/ijc.31742] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
356 Liu W, Wang Y, Huang H, Fackche N, Rodgers K, Lee B, Nizam W, Khan H, Lu Z, Kong X, Li Y, Liang N, Zhao X, Jin X, Liu H, Talbot CC, Huang P, Eshleman JR, Lai Q, Zhang Y, Brock MV, Mei Y. A Cost-Effective and Non-Invasive pfeRNA-Based Test Differentiates Benign and Suspicious Pulmonary Nodules from Malignant Ones. ncRNA 2021;7:80. [DOI: 10.3390/ncrna7040080] [Reference Citation Analysis]
357 Kapeleris J, Kulasinghe A, Warkiani ME, Vela I, Kenny L, O'Byrne K, Punyadeera C. The Prognostic Role of Circulating Tumor Cells (CTCs) in Lung Cancer. Front Oncol 2018;8:311. [PMID: 30155443 DOI: 10.3389/fonc.2018.00311] [Cited by in Crossref: 50] [Cited by in F6Publishing: 57] [Article Influence: 12.5] [Reference Citation Analysis]
358 Zhang F, Wu X, Zhu J, Huang Y, Song X, Jiang L. 18F-FDG PET/CT and circulating tumor cells in treatment-naive patients with non-small-cell lung cancer. Eur J Nucl Med Mol Imaging 2021;48:3250-9. [PMID: 33630146 DOI: 10.1007/s00259-021-05260-z] [Reference Citation Analysis]
359 Pacia CP, Zhu L, Yang Y, Yue Y, Nazeri A, Michael Gach H, Talcott MR, Leuthardt EC, Chen H. Feasibility and safety of focused ultrasound-enabled liquid biopsy in the brain of a porcine model. Sci Rep 2020;10:7449. [PMID: 32366915 DOI: 10.1038/s41598-020-64440-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
360 Harada K, Mizrak Kaya D, Baba H, Ajani JA. Recent advances in preoperative management of esophageal adenocarcinoma. F1000Res 2017;6:501. [PMID: 28491289 DOI: 10.12688/f1000research.10794.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
361 Fernández-Lázaro D, Hernández JLG, García AC, Castillo ACD, Hueso MV, Cruz-Hernández JJ. Clinical Perspective and Translational Oncology of Liquid Biopsy. Diagnostics (Basel) 2020;10:E443. [PMID: 32629823 DOI: 10.3390/diagnostics10070443] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
362 Yankaskas CL, Thompson KN, Paul CD, Vitolo MI, Mistriotis P, Mahendra A, Bajpai VK, Shea DJ, Manto KM, Chai AC, Varadarajan N, Kontrogianni-Konstantopoulos A, Martin SS, Konstantopoulos K. A microfluidic assay for the quantification of the metastatic propensity of breast cancer specimens. Nat Biomed Eng 2019;3:452-65. [PMID: 31061459 DOI: 10.1038/s41551-019-0400-9] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 12.0] [Reference Citation Analysis]
363 Zhang Y, Yao Y, Xu Y, Li L, Gong Y, Zhang K, Zhang M, Guan Y, Chang L, Xia X, Li L, Jia S, Zeng Q. Pan-cancer circulating tumor DNA detection in over 10,000 Chinese patients. Nat Commun 2021;12:11. [PMID: 33397889 DOI: 10.1038/s41467-020-20162-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
364 Dhar M, Lam JN, Walser T, Dubinett SM, Rettig MB, Di Carlo D. Functional profiling of circulating tumor cells with an integrated vortex capture and single-cell protease activity assay. Proc Natl Acad Sci U S A 2018;115:9986-91. [PMID: 30224472 DOI: 10.1073/pnas.1803884115] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 14.3] [Reference Citation Analysis]
365 Wei L, Hussein AA, Ma Y, Azabdaftari G, Ahmed Y, Wong LP, Hu Q, Luo W, Cranwell VN, Bunch BL, Kozlowski JD, Singh PK, Glenn ST, Smith G, Johnson CS, Liu S, Guru KA. Accurate Quantification of Residual Cancer Cells in Pelvic Washing Reveals Association with Cancer Recurrence Following Robot-Assisted Radical Cystectomy. J Urol 2019;201:1105-14. [PMID: 30730413 DOI: 10.1097/JU.0000000000000142] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 3.3] [Reference Citation Analysis]
366 Wei F, Strom CM, Cheng J, Lin CC, Hsu CY, Soo Hoo GW, Chia D, Kim Y, Li F, Elashoff D, Grognan T, Tu M, Liao W, Xian R, Grody WW, Su WC, Wong DTW. Electric Field-Induced Release and Measurement Liquid Biopsy for Noninvasive Early Lung Cancer Assessment. J Mol Diagn 2018;20:738-42. [PMID: 30309763 DOI: 10.1016/j.jmoldx.2018.06.008] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
367 Song Y, Hu C, Xie Z, Wu L, Zhu Z, Rao C, Liu L, Chen Y, Liang N, Chen J, Yang N, Hu J, Zhao W, Tong G, Dong X, Zheng D, Jin M, Huang M, He Y, Rosell R, Lippi G, Mino-Kenudson M, Han-Zhang H, Mao X, Zhang L, Liu H, Field JK, Chuai S, Ye J, Han Y, Lu S;  Written on behalf of AME Lung Cancer Collaborative Group. Circulating tumor DNA clearance predicts prognosis across treatment regimen in a large real-world longitudinally monitored advanced non-small cell lung cancer cohort. Transl Lung Cancer Res. 2020;9:269-279. [PMID: 32420066 DOI: 10.21037/tlcr.2020.03.17] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
368 Koncina E, Haan S, Rauh S, Letellier E. Prognostic and Predictive Molecular Biomarkers for Colorectal Cancer: Updates and Challenges. Cancers (Basel). 2020;12. [PMID: 32019056 DOI: 10.3390/cancers12020319] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 12.5] [Reference Citation Analysis]
369 Fernández-Lázaro D, García Hernández JL, García AC, Córdova Martínez A, Mielgo-Ayuso J, Cruz-Hernández JJ. Liquid Biopsy as Novel Tool in Precision Medicine: Origins, Properties, Identification and Clinical Perspective of Cancer's Biomarkers. Diagnostics (Basel) 2020;10:E215. [PMID: 32294884 DOI: 10.3390/diagnostics10040215] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 14.0] [Reference Citation Analysis]
370 Ikeda M, Koh Y, Teraoka S, Sato K, Kanai K, Hayata A, Tokudome N, Akamatsu H, Ozawa Y, Akamatsu K, Endo K, Higuchi M, Nakanishi M, Ueda H, Yamamoto N. Detection of AXL expression in circulating tumor cells of lung cancer patients using an automated microcavity array system. Cancer Med 2020;9:2122-33. [PMID: 31999390 DOI: 10.1002/cam4.2846] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
371 Veyssière H, Lusho S, Molnar I, Kossai M, Bernadach M, Abrial C, Bidet Y, Radosevic-Robin N, Durando X. INSTIGO Trial: Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse of Triple Negative Breast Cancer. Front Oncol 2021;11:653370. [PMID: 34249690 DOI: 10.3389/fonc.2021.653370] [Reference Citation Analysis]
372 Han J, Gao L, Wang J, Wang J. Application and development of aptamer in cancer: from clinical diagnosis to cancer therapy. J Cancer 2020;11:6902-15. [PMID: 33123281 DOI: 10.7150/jca.49532] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
373 Boral D, Liu HN, Kenney SR, Marchetti D. Molecular Interplay between Dormant Bone Marrow-Resident Cells (BMRCs) and CTCs in Breast Cancer. Cancers (Basel) 2020;12:E1626. [PMID: 32575420 DOI: 10.3390/cancers12061626] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
374 Zhao G, Zhou A, Li X, Zhu S, Wang Y, Zhang S, Li P. The Significance of Exosomal RNAs in the Development, Diagnosis, and Treatment of Gastric Cancer. Genes (Basel) 2021;12:73. [PMID: 33430032 DOI: 10.3390/genes12010073] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
375 Ory EC, Chen D, Chakrabarti KR, Zhang P, Andorko JI, Jewell CM, Losert W, Martin SS. Extracting microtentacle dynamics of tumor cells in a non-adherent environment. Oncotarget 2017;8:111567-80. [PMID: 29340075 DOI: 10.18632/oncotarget.22874] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
376 Maurice Dror C, Chi KN, Khalaf DJ. Finding the optimal treatment sequence in metastatic castration-resistant prostate cancer-a narrative review. Transl Androl Urol 2021;10:3931-45. [PMID: 34804836 DOI: 10.21037/tau-20-1341] [Reference Citation Analysis]
377 Ramón Y Cajal S, Sesé M, Capdevila C, Aasen T, De Mattos-Arruda L, Diaz-Cano SJ, Hernández-Losa J, Castellví J. Clinical implications of intratumor heterogeneity: challenges and opportunities. J Mol Med (Berl) 2020;98:161-77. [PMID: 31970428 DOI: 10.1007/s00109-020-01874-2] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 27.5] [Reference Citation Analysis]
378 Podolak J, Eilers K, Newby T, Slottke R, Tucker E, Olson SB, Lue HW, Youngren J, Aggarwal R, Small EJ, Graff JN, Alumkal JJ, Beer TM, Thomas GV. Androgen receptor amplification is concordant between circulating tumor cells and biopsies from men undergoing treatment for metastatic castration resistant prostate cancer. Oncotarget 2017;8:71447-55. [PMID: 29069718 DOI: 10.18632/oncotarget.16169] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
379 Hussung S, Akhoundova D, Hipp J, Follo M, Klar RFU, Philipp U, Scherer F, von Bubnoff N, Duyster J, Boerries M, Wittel U, Fritsch RM. Longitudinal analysis of cell-free mutated KRAS and CA 19-9 predicts survival following curative resection of pancreatic cancer. BMC Cancer 2021;21:49. [PMID: 33430810 DOI: 10.1186/s12885-020-07736-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
380 Tzanikou E, Markou A, Politaki E, Koutsopoulos A, Psyrri A, Mavroudis D, Georgoulias V, Lianidou E. PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study. Mol Oncol 2019;13:2515-30. [PMID: 31254443 DOI: 10.1002/1878-0261.12540] [Cited by in Crossref: 27] [Cited by in F6Publishing: 1] [Article Influence: 9.0] [Reference Citation Analysis]
381 Sol N, Wurdinger T. Platelet RNA signatures for the detection of cancer. Cancer Metastasis Rev 2017;36:263-72. [PMID: 28681241 DOI: 10.1007/s10555-017-9674-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 8.8] [Reference Citation Analysis]
382 Rizvi S, Eaton J, Yang JD, Chandrasekhara V, Gores GJ. Emerging Technologies for the Diagnosis of Perihilar Cholangiocarcinoma. Semin Liver Dis. 2018;38:160-169. [PMID: 29871021 DOI: 10.1055/s-0038-1655775] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
383 Sevenler D, Trueb J, Ünlü MS. Beating the reaction limits of biosensor sensitivity with dynamic tracking of single binding events. Proc Natl Acad Sci U S A 2019;116:4129-34. [PMID: 30782809 DOI: 10.1073/pnas.1815329116] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
384 Battista E, Causa F, Netti PA. Bioengineering Microgels and Hydrogel Microparticles for Sensing Biomolecular Targets. Gels 2017;3:E20. [PMID: 30920517 DOI: 10.3390/gels3020020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 2.6] [Reference Citation Analysis]
385 Roviello G, Aprile G, D'Angelo A, Iannone LF, Roviello F, Polom K, Mini E, Catalano M. Human epidermal growth factor receptor 2 (HER2) in advanced gastric cancer: where do we stand? Gastric Cancer 2021;24:765-79. [PMID: 33742317 DOI: 10.1007/s10120-021-01182-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
386 Wang H, Zhou F, Qiao M, Li X, Zhao C, Cheng L, Chen X, Zhou C. The Role of Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis. Front Oncol 2021;11:671874. [PMID: 34367957 DOI: 10.3389/fonc.2021.671874] [Reference Citation Analysis]
387 Chen X, Tong Y, Shi Z, Chen H, Yang Z, Wang Y, Chen L, Yu J. Noninvasive molecular diagnosis of craniopharyngioma with MRI-based radiomics approach. BMC Neurol 2019;19:6. [PMID: 30616515 DOI: 10.1186/s12883-018-1216-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
388 Weng JY, Salazar N. DNA Methylation Analysis Identifies Patterns in Progressive Glioma Grades to Predict Patient Survival. Int J Mol Sci 2021;22:1020. [PMID: 33498463 DOI: 10.3390/ijms22031020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
389 Sharbatoghli M, Vafaei S, Aboulkheyr Es H, Asadi-Lari M, Totonchi M, Madjd Z. Prediction of the treatment response in ovarian cancer: a ctDNA approach. J Ovarian Res 2020;13:124. [PMID: 33076944 DOI: 10.1186/s13048-020-00729-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
390 Arend RC, Londoño AI, Montgomery AM, Smith HJ, Dobbin ZC, Katre AA, Martinez A, Yang ES, Alvarez RD, Huh WK, Bevis KS, Straughn JM Jr, Estes JM, Novak L, Crossman DK, Cooper SJ, Landen CN, Leath CA 3rd. Molecular Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma. Mol Cancer Res 2018;16:813-24. [PMID: 29523763 DOI: 10.1158/1541-7786.MCR-17-0594] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
391 Hofman P. Liquid Biopsy and Therapeutic Targets: Present and Future Issues in Thoracic Oncology. Cancers (Basel) 2017;9:E154. [PMID: 29125548 DOI: 10.3390/cancers9110154] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
392 Lee JS, Park SS, Lee YK, Norton JA, Jeffrey SS. Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA. Mol Oncol 2019;13:1623-50. [PMID: 31243883 DOI: 10.1002/1878-0261.12537] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
393 Nagayama S, Low SK, Kiyotani K, Nakamura Y. Precision Medicine for Colorectal Cancer with Liquid Biopsy and Immunotherapy. Cancers (Basel) 2021;13:4803. [PMID: 34638288 DOI: 10.3390/cancers13194803] [Reference Citation Analysis]
394 Makita K, Nishimoto K, Kiriyama-Kitamoto K, Karashima S, Seki T, Yasuda M, Matsui S, Omura M, Nishikawa T. A Novel Method: Super-selective Adrenal Venous Sampling. J Vis Exp 2017. [PMID: 28994759 DOI: 10.3791/55716] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
395 Prouteau A, Denis JA, De Fornel P, Cadieu E, Derrien T, Kergal C, Botherel N, Ulvé R, Rault M, Bouzidi A, François R, Dorso L, Lespagnol A, Devauchelle P, Abadie J, André C, Hédan B. Circulating tumor DNA is detectable in canine histiocytic sarcoma, oral malignant melanoma, and multicentric lymphoma. Sci Rep 2021;11:877. [PMID: 33441840 DOI: 10.1038/s41598-020-80332-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
396 Huang Q, Li N, Zhang H, Che C, Sun F, Xiong Y, Canady TD, Cunningham BT. Critical Review: digital resolution biomolecular sensing for diagnostics and life science research. Lab Chip 2020;20:2816-40. [PMID: 32700698 DOI: 10.1039/d0lc00506a] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
397 Mondelo-Macía P, García-González J, León-Mateos L, Castillo-García A, López-López R, Muinelo-Romay L, Díaz-Peña R. Current Status and Future Perspectives of Liquid Biopsy in Small Cell Lung Cancer. Biomedicines 2021;9:48. [PMID: 33430290 DOI: 10.3390/biomedicines9010048] [Reference Citation Analysis]
398 Earl J, Barreto E, Castillo ME, Fuentes R, Rodríguez-Garrote M, Ferreiro R, Reguera P, Muñoz G, Garcia-Seisdedos D, López JV, Sainz B Jr, Malats N, Carrato A. Somatic Mutation Profiling in the Liquid Biopsy and Clinical Analysis of Hereditary and Familial Pancreatic Cancer Cases Reveals KRAS Negativity and a Longer Overall Survival. Cancers (Basel) 2021;13:1612. [PMID: 33807330 DOI: 10.3390/cancers13071612] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
399 Necula L, Matei L, Dragu D, Neagu AI, Mambet C, Nedeianu S, Bleotu C, Diaconu CC, Chivu-Economescu M. Recent advances in gastric cancer early diagnosis. World J Gastroenterol 2019; 25(17): 2029-2044 [PMID: 31114131 DOI: 10.3748/wjg.v25.i17.2029] [Cited by in CrossRef: 76] [Cited by in F6Publishing: 70] [Article Influence: 25.3] [Reference Citation Analysis]
400 Hu M, Wang Z, Wu Z, Ding P, Pei R, Wang Q, Xing C. Circulating tumor cells in colorectal cancer in the era of precision medicine. J Mol Med (Berl) 2021. [PMID: 34802071 DOI: 10.1007/s00109-021-02162-3] [Reference Citation Analysis]
401 Sánchez-Calderón D, Pedraza A, Mancera Urrego C, Mejía-Mejía A, Montealegre-Páez AL, Perdomo S. Analysis of the Cost-Effectiveness of Liquid Biopsy to Determine Treatment Change in Patients with Her2-Positive Advanced Breast Cancer in Colombia. Clinicoecon Outcomes Res 2020;12:115-22. [PMID: 32104023 DOI: 10.2147/CEOR.S220726] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
402 Pogribny IP. MicroRNAs as biomarkers for clinical studies. Exp Biol Med (Maywood). 2018;243:283-290. [PMID: 28914096 DOI: 10.1177/1535370217731291] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 8.2] [Reference Citation Analysis]
403 Ma S, Shi M, Chen X, Wang Y, Yang Z, Lizaso A, Li M, Li H, Zhang L, Mao X, Xu X, Song Y. The prognostic value of longitudinal circulating tumor DNA profiling during osimertinib treatment. Transl Lung Cancer Res 2021;10:326-39. [PMID: 33569316 DOI: 10.21037/tlcr-20-371] [Reference Citation Analysis]
404 Manier S, Park J, Capelletti M, Bustoros M, Freeman SS, Ha G, Rhoades J, Liu CJ, Huynh D, Reed SC, Gydush G, Salem KZ, Rotem D, Freymond C, Yosef A, Perilla-Glen A, Garderet L, Van Allen EM, Kumar S, Love JC, Getz G, Adalsteinsson VA, Ghobrial IM. Whole-exome sequencing of cell-free DNA and circulating tumor cells in multiple myeloma. Nat Commun 2018;9:1691. [PMID: 29703982 DOI: 10.1038/s41467-018-04001-5] [Cited by in Crossref: 83] [Cited by in F6Publishing: 78] [Article Influence: 20.8] [Reference Citation Analysis]
405 Pantel K. Blood-Based Analysis of Circulating Cell-Free DNA and Tumor Cells for Early Cancer Detection. PLoS Med 2016;13:e1002205. [PMID: 28027295 DOI: 10.1371/journal.pmed.1002205] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 6.7] [Reference Citation Analysis]